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THE COUPLING OF REGIONAL CEREBRAL BLOOD FLOW TO NEURONAL 
ACTIVITY IS IN PART MEDIATED BY NITRIC OXIDE AND ADENOSINE. 
Michael G. Kaiser*, Matthew J. During. Section of Neurosurgery, Department 
of Surgery, Yale University, School of Medicine, New Haven, CT. 
The coupling of regional cerebral blood flow to neuronal activity is 
supported through a multitude of studies, however the factors responsible 
remain unidentified. In the present study we investigated whether nitric 
oxide and adenosine are involved in this coupling. Rats underwent 
unilateral placement of both a microdialysis and laser doppler probe into the 
CA1/dentate hilus of the hippocampus. Regional blood flow changes were 
recorded with the laser doppler and represented as percent of baseline. 
Microdialysis was used to deliver pharmacological agents and analyze the 
interstitial fluid for adenosine and citrulline release, an index of nitric oxide 
synthesis. The first group receiving increasing doses of NMDA (n=10), 
responded in a dose dependent manner with increases of 106.8+2.3%, 
120.0+6.3%, 148.0±16.6%, 191.4+20.4% at 50, 100, 200, and 500 pM NMDA. 
Both citrulline and adenosine demonstrated significant increases from 
baseline. Animals receiving a direct nitric oxide donor (n=6), demonstrated 
increases of regional blood flow to 137.0+5.8%. Inhibition of nitric oxide 
synthase, with NG-nitro-L-arginine methyl ester, decreased basal flow to 
77.0+3.0% of baseline (n=9), and attenuated the response of 200 pM NMDA 
from 164.0+17.4% to 125.0+6.5% of baseline (n=7). The effects of this inhibitor 
were significantly reduced by simultaneous infusion L-arginine (n=6). Basal 
and NMDA induced citrulline release were significantly decreased with NG- 
nitro- L-arginine methyl ester . The adenosine receptor antagonist, 8-(p-sulfo- 
phenyl) theophylline, also decreased both basal blood flow and the response 
to 200 pM NMDA (n=5). Preliminary results indicate that stimulation of the 

/ 
perforant pathway increases cerebral blood flow in the hippocampus (n=2). 
Studies are presently underway to characterize the mediators of this response. 
Based on these results nitric oxide and adenosine participate in the coupling 




A. Opening Remarks 
"The chemical products of cerebral metabolism contained in the 
lymph which bathes the walls of the arterioles of the brain can cause 
variations of the calibre of the cerebral vessels. In this reaction the 
brain possesses an intrinsic mechanism by which its vascular supply 
can be varied locally in correspondence with local variations of 
functional activity." 
-Roy and Sherrington 1890 
This statement is generally considered the foundation for research 
which investigates the coupling of regional cerebral blood flow (rCBF) to 
neuronal activity. This postulate was truly ahead of its time, especially since 
the ability to quantitatively measure and demonstrate definitive changes in 
rCBF was not developed until the early 1950's. Since then a multitude of 
studies have demonstrated this relationship, however the "intrinsic 
mechanism" alluded to by Roy and Sherrington, responsible for this 
coupling, remains to be identified. Factors which have been considered 
include locally released products of metabolism, decreased tissue p02, 
potassium ions released with neuronal depolarization, and 
neurotransmitters. All of these substances were in vogue at one time or 
another and shown to alter rCBF, however convincing evidence identifying 
them as the direct link between rCBF and neuronal activity is lacking. 
Progress in resolving this issue was only possible with advancements 
in the techniques which monitor rCBF. Over the years these new methods 
have not only simplified measurements, but also improved the temporal and 
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spatial resolution. Such techniques have demonstrated an instantaneous 
increase in rCBF within the specific vascular bed supplying an individual 
group of neurons. Unfortunately what the previous studies lacked was the 
ability to observe mediators released in the extracellular fluid while changes 
in rCBF were being measured. To truly gain an understanding of this 
relationship, such a method must be developed which would allow mediator 
release to be correlated with increases in rCBF during neuronal activation. 
B. Development of a Suitable Method 
Throughout most of the 1800's cerebral blood flow (CBF) was generally 
thought to be constant (ladecola 1993). This assumption was derived from the 
Monro-Kellie Doctrine, formulated in 1783, which in part states, "...quantity 
of blood within the head must be the same, or very nearly the same, at all 
times , whether in health or disease, in life or after death...," and was based on 
the rigid nature of the skull and the inability of the brain to undergo 
significant compression. Since no methods to monitor CBF were available at 
this time, the hypothesis went unchallenged. Even as late as 1936 significant 
uncertainty remained. After reviewing the available literature, HG Wolff 
came to the conclusion that knowledge on CBF was deficient, "Unfortunately, 
the amount of blood going to the brain still remains an uncertain quantity," 
(Wolff 1936). 
Prior to this date quantitative measures of CBF were attempted by 
observing the perfusion through cerebral vessels of excised brains. These 
studies were clearly far from ideal and involved enormous errors. In 1943 
Dumke and Schmidt provided some of the first reliable quantifications of 
CBF by timing the passage of an injected air bubble through a flowmeter 
which contained blood diverted from the cerebral circulation, the bubble 
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flowmeter. Although still producing non-physiological measurements, it 
was considered "less abnormal" than the previous methods (Dumke and 
Schmidt 1943). The first quantitative measurements of human CBF were 
made in 1945 using inhalation of nitrous oxide gas. The method is based on 
the Fick equation of continuity which determines blood flow through an 
organ by dividing the organ's consumption of a particular substance by the 
arterio-venous concentration difference of that substance. This came to be 
known as the Kety-Schmidt method (Kety and Schmidt 1945; Kety and 
Schmidt 1948). It became the standard for CBF measurements over the next 
decade, modified by using different tracer substances, such as ^Krypton 
which increased technical accuracy (Lassen and Munck 1955). Another 
technique available at this time was the indicator-dilution method. Either 
dye or radioactively labeled erythrocytes were injected into the arterial 
cerebral circulation and dilution of the tracer was observed by repeated 
sampling of the jugular venous blood. The sample concentrations were 
plotted over time, producing a dilution curve. CBF was determined through 
mathematical computations involving the area under the dilution curve 
(Nylin and Blomer 1955). Although both of these techniques possessed 
inherent limitations, the inability to distinguish blood flow within various 
segments of the brain, the inability to measure rCBF, was the most significant. 
Qualitative observations of rCBF had been made since the 1920's by 
direct visualization of pial vessels (Florey 1925), counting tissue capillaries 
(Cobb and Talbott 1927), and locally implanted thermoelectric devices (Gibbs 
1933). Not until 1958, with the advancement of autoradiographic techniques 
was a method available which demonstrated quantitative differences in flow 
between various macrostructures of the brain. This technique, similar to the 
Kety-Schmidt method, is also based on the Fick principle. CBF is determined 
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by the exchange of a biologically inert tracer between the blood and the tissue. 
After administration of a radioactive tracer, flow per unit weight of tissue is 
computed by determining the change in arterial concentration of the tracer 
over a specified time period, the tissue:blood partition coefficient, and the 
concentration of tracer in the specific brain locus. The tissue concentration is 
determined from the optical density produced on a radiograph (Freygang and 
Sokoloff 1958). This method however, still failed to demonstrate flow within 
specific microcirculatory beds. More important was the inability to make 
repeated observations since each measurement required sacrificing the 
subject. This not only made continuous monitoring impossible but also 
precluded such a method from human investigations. Development of 
additional techniques continued throughout the 1960's and include the 
radioisotope clearance method, the hydrogen clearance method, and the 
radiolabeled microsphere technique. 
The radiolabeled microsphere technique resembles previous auto¬ 
radiographic methods for determining local blood flow. Instead of an inert 
gas, carbon microspheres are used as the radioactive tracer. The optical 
density on the radiographs depends on the amount of microspheres which 
become trapped in the tissue capillaries. This method is valid only under the 
assumptions that the microspheres are too large to pass through the 
capillaries of the tissue, the particles mix uniformly within the blood stream, 
and they are not metabolized (Roth et al 1970). Important limitations include 
the inability to produce more than one measurement per subject, the use of a 
radioactive substance, the need for repeated blood sampling, and variability 
secondary to non-random distribution of microspheres from inadequate 
mixing and recirculation (Buckberg et al 1971). 
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The hydrogen clearance method determines flow based on the current 
produced by hydrogen delivery to an implanted probe. Hydrogen gas inspired 
by the subject equilibrates in the tissues and produces current in proportion to 
its concentration. The inspiration of hydrogen is then stopped and the 
concentration decreases at the tissue site as the gas is removed by the local 
blood flow. This decrease in the concentration of hydrogen causes the current 
to decrease. The rCBF is determined from the curve of the decreasing current 
(Haining et al 1968). Limitations of this method include tissue trauma 
produced by probe implantation, variability due to diffusion of hydrogen into 
the tissues, inability to follow rapid changes in rCBF, and complex data 
analysis and interpretation (Skarphedinsson et al 1988, Halsey et al 1977, 
Lacombe et al 1980). 
Radioisotope clearance methods determine flow by observing the 
decrease in radioactivity of various brain regions over time. A diffusable 
radioactive tracer is injected, or inhaled, and enters the tissue blood stream. 
This tracer then diffuses across the endothelium and is taken up by the tissue. 
The radioactivity is then measured with extracranial detectors. The rate of 
clearance of the tracer depends on the blood flow to the area in question 
(Ingvar and Lassen 1962) This method however requires radioactive 
substances, has a poor spatial resolution due to extracranial detection, and 
requires complex data analysis with instability of results due to tracer 
recirculation and diffusion (Holti and Mitchell 1978; Holloway 1980). An 
improvement in spatial resolution was achieved by coupling this technique 
to CT imaging (Drayer et al 1978), but this modification resulted in new 
sources of error (Good et al 1982). 
Although the hydrogen clearance and radioisotope washout methods 
allow repeated measurements for each subject, they are still unable to make 
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continuous recordings and demonstrate instantaneous changes in blood flow. 
Such an ability could correlate rapid changes in rCBF with release of putative 
mediators. Recent developments in non-invasive imaging techniques, such 
as functional magnetic resonance imaging which monitor flow based on 
deoxyhemoglobin tissue content, has a time resolution of less than two 
seconds, the ability for repeated measurements, and a spatial resolution as 
small as 4-6 mm (Schulman et al 1993). These techniques however are still in 
development, require great expense, and have a very limited availability. 
Over the last twenty years one technique has been developed which 
has significant advantages over the existing methods This technique is 
known as laser doppler flowmetry (LDF) (Stern 1975). LDF is based on the 
frequency shift that occurs to laser light when it is reflected off a moving 
object, the Doppler effect. The laser light is emitted into a tissue through a 
fiber optic guide. This light penetrates thin walled vessels, such as small 
arterioles, venules, and capillaries. The light is randomly reflected by blood 
cells, those in motion will produce a frequency shift in the light. Some of this 
reflected light is returned to the probe and consists of both unshifted and 
Doppler shifted frequencies. The laser doppler unit determines rCBF from 
the differences in these frequencies. Since the majority of moving cells 
reflecting the light are red blood cells, the value obtained is a measure of their 
flow. A detailed description of the principles behind LDF are discussed in 
Appendix IA. The major advantages of LDF over existing techniques include 
the ability to make continuous measurements of blood flow (Oeberg et al 
1984), a spatial resolution within 2mm3 (Eyre et al 1988), a temporal 
resolution within the millisecond range (Lindauer et al 1993), and LDF does 
not require invasive manipulations (Oeberg et a 1984). Initially the 
technique's major application was measurements of the skin 
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microcirculation (Allen and Goldman 1987; Braverman 1990), however its 
value in measuring rCBF has quickly been recognized (Eyre et al. 1988; 
Dirnagl et al. 1989; Haberl et al. 1989, and Lindauer et al 1993). As with other 
techniques there are limitations with LDF. The primary disadvantage is the 
inability to quantify blood flow in terms of volume per time. Therefore data 
from LDF must be represented as percent changes in rCBF (Dirnagl et al 1989). 
Other minor limitations, including a high sensitivity to movement artifact, 
can be overcome with carefully controlled experimental conditions. 
Although LDF is able to reflect instantaneous changes in rCBF with increased 
neuronal activity, it does not possess any intrinsic ability to identify possible 
mediators released in the extracellular fluid. To investigate the factors 
responsible for the coupling of rCBF to activity, an additional technique is 
needed to meet this requirement. 
Over the years a number of techniques have been developed which 
allow the determination of substances within the brain interstitial fluid. 
These can be divided into those which make in situ measurements and those 
which require ex situ analysis. The in situ methods include ion-selective 
microelectrodes which are able to only identify ions (Thomas 1978), and 
carbon fiber microelectrodes which only detect oxidizable substances 
(Marsden et al 1984). Major limitations are associated with each method. 
Carbon microelectrodes have a reduced selectivity when measuring 
substances with similar oxidation potentials, both methods consume the 
species being measured, and both have a short working life in vivo 
(Benveniste 1989). The ex situ methods include the cortical cup (Dodd and 
Bradford 1974), the push-pull cannula (Pillippu 1984) and brain microdialysis 
(Bito et al 1966; Delgado et al 1972; and Ungerstedt 1984). The former two 
techniques have a poor temporal resolution (>10 minutes), the cortical cup 
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can only measure cortical fluid, push-pull cannulae produce a significant 
amount of tissue trauma, samples obtained from both methods require 
deproteinization prior to analysis by high pressure liquid chromatography 
(HPLC), and considerable amount of enzyme degradation within samples can 
occur before measurements are made (Benveniste 1989). Microdialysis is an 
established method to evaluate the extracellular environment, and has 
arguably become the standard technique for in vivo neurochemical 
measurements (Robinson and Justice 1991). In principle microdialysis can 
collect virtually any substance in any area of the brain with minimal tissue 
trauma. The theory behind microdialysis is based on the simple diffusion of 
substances down their concentration gradients. An artificial fluid, lacking the 
substance to be measured, is passed through the microdialysis probe. As a 
tissue releases the substance it will diffuse across the permeable microdialysis 
membrane and enter the artificial fluid within the probe. This fluid is 
continuously pumped through the probe, collected at an outlet, and analyzed 
by techniques such as HPLC (Benveniste 1989). A detailed description of the 
mechanics can be found in Appendix A. A major advantage of microdialysis 
is the ability to not only sample the extracellular fluid but also to deliver 
pharmacological agents to the local parenchyma without producing systemic 
effects. This allows the activity of a specific group of neurons to be 
manipulated, avoiding the release of mediators from other peripheral tissues, 
such as endothelial cells, which may alter blood flow. As with all 
experimental techniques there are disadvantages to microdialysis. Obtaining 
the actual concentration of a substance within the extracellular fluid requires 
complex data interpretation that is based on assumptions which are not 
necessarily valid. Results are therefore generally represented as percent 
changes from baseline values. Also the probes are extremely delicate and can 
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easily break if not handled properly. In spite of these limitations, the 
combination of both laser doppler flowmetry with brain microdialysis should 
prove to be a powerful tool in the investigation of the coupling of rCBF to 
neuronal activity. 
C. Regulation of CBF 
The regulation of cerebral perfusion occurs at two separate levels. One 
level determines the overall perfusion of the brain, designated as mean 
cerebral blood flow (mCBF). The second distributes blood to specific neuronal 
groups during increased activity, known as rCBF. Since in essence rCBF 
ultimately depends on mCBF, and regulatory mechanisms may be shared 
between the two, it is important to first obtain an understanding of mCBF 
regulation. 
i. Regulation of mCBF 
Prior to monitoring mCBF it was known that arterial pressure was the 
driving force for the cerebral circulation, however the question of whether 
the brain had the intrinsic power to change mCBF was unanswered (Hill and 
MacLeod 1900). With the ability to quantitate mCBF, studies demonstrated 
changes in this flow and factors other than systemic pressure which could 
alter it. In 1943 Dumke and Schmidt, using the bubble flowmeter in 
monkeys, demonstrated increases in mCBF with anoxemia and hypercapnia, 
while decreased mCBF occurred with hyperoxia (Dumke and Schmidt 1943). 
This was one of the first studies which demonstrated an intrinsic control of 
cerebral vascular tone. Kety and Schmidt describe not only their method to 
measure mCBF but also the effects of increased intracranial pressure (ICP), 
hyperventilation, and changes in arterial tensions of CO2 and O2. In a study 
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to determine the effects of hyperventilation on military pilots, Kety and 
Schmidt demonstrated a reduction of 33%-35% in mCBF with 
hyperventilation (Kety and Schmidt 1946). Using patients with known 
intracranial tumors, increased ICP was associated with an increase in cerebral 
vascular resistance and an eventual reduction in mCBF (Kety and Schmidt 
1948). Increases in mCBF of 75% and 35% were reported during inhalation of 
5%-7% CO2 and 10% O2 respectively. Increasing the concentration of inhaled 
O2 to 85%-100% decreased mCBF by 13% (Kety and Schmidt 1948). Even 
though these substances were shown to affect mCBF it was still believed in 
1950 that mCBF fluctuated freely with systemic blood pressure (Schmidt 1950). 
In 1964 an autoregulatory response in canine mCBF was demonstrated. Its 
control was mediated by the release of the metabolic factors which had 
previously been shown to alter mCBF, including CO2, H+, and O2. It was also 
proposed that these factors could inhibit the autoregulatory response through 
excessive vasodilatation (Rapela and Green 1964). In 1968 Plum and Posner 
demonstrated this inhibition with a global increase in tissue CO2 production 
during induced seizures. A reported increase of 264% in mCBF occurred with 
a 72 mm Hg increase in systemic blood pressure. This increase was attributed 
to the loss of autoregulation and passive response of mCBF to arterial blood 
pressure (Plum et al 1968). These and other studies have demonstrated the 
principles which govern regulation of mCBF. 
Consistent delivery of blood to the brain is extremely important. The 
brain, while only 2% of body weight, requires 15% of the total cardiac output 
and 20% of total body oxygen consumption. These requirements demonstrate 
how dependent the brain is on oxidative metabolism, without a significant 
reserve for glycolysis (Chien 1985). The main determinants of mCBF include 
arterial pressure, blood viscosity, and cerebral vascular resistance. Arterial 
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pressure is mainly determined from the cardiac output and systemic 
resistance, while blood viscosity is mainly a function of hematocrit. Cerebral 
arterial resistance is primarily determined by the radius of the vessel, since 
resistance is proportional to the fourth power of the radius. Factors which 
control the tone of the large cerebral vessels therefore have a profound effect 
on mCBF. These factors include the rigid cranium housing the brain, 
neuronal innervation, and autoregulation (Chien 1985; Guyton 1986). 
Although original assumptions of mCBF based on the Monro-Kellie 
doctrine were incorrect, its principles are a determinant of extraparenchymal 
vascular resistance. ICP is produced by the four major components within 
the cranium; blood, cerebrospinal fluid, interstitial fluid, and brain tissue. 
Volume increases of one must be compensated by decreases in the others. 
Small fluctuations in ICP occur under normal physiological conditions, such 
as respiration. These changes do not produce harmful sequelae, mainly 
through the ability of the venous sinuses to undergo compression. 
Intracerebral arteries are able to resist such small increases in ICP by reducing 
the active tension in the vessel wall through smooth muscle relaxation 
(Chien 1985). Excessive relaxation however will lead to stretching of 
neighboring dural structures and produce pain. This is thought to be one 
etiologic agents of a headache (Martin 1991). The effects of an elevated ICP on 
mCBF are more pronounced under pathological conditions. For instance, 
large increases in ICP may produce displacement of brain tissue, known as 
herniation, and compress vessels leading to total disruption of blood flow 
(Morris and Phil 1989). 
Another contributor to the regulation of mCBF is neuronal innerva¬ 
tion of large extraparenchymal vessels. These neurons are derived from a 
number of cranial nerve ganglia and contain a multitude of neuro- 
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transmitters. Their precise function remains to be determined. Projections 
from the ophthalmic division of the trigeminal nerve, via the nasociliary 
nerve, have been shown to innervate the vessels making up the Circle of 
Willis and portions of the basilar artery (Keller et al 1985; Suzuki et al 1989). 
Neurotransmitters identified within these fibers include substance P, 
calcitonin gene-related peptide (CGRP), and galanin The function of these 
fibers is presumably sensory (Edvinsson 1985; Owman et al 1989; Suzuki et al 
1989). Sympathetic fibers originating from the superior cervical ganglion and 
stellate ganglion innervate these same vessels as well as smaller pial arteries 
and arterioles. The terminals contain not only norepinephrine (NE), but also 
neuropeptide Y (NPY) (Lou et al 1987; Edvinsson et al 1989). Stimulation 
produces cerebral vasoconstriction, however this effect is weak compared to 
systemic sympathetic vasoconstriction (Chien 1985). A third group of fibers, 
originating from the sphenopalatine ganglion contains enzymes capable of 
producing acetylcholine (ACh), nitric oxide (NO), and vasoactive intestinal 
peptide (VIP) (Nozaki et al 1993; Edvinsson et al 1972). Other sources of ACh 
containing neurons include the otic ganglia, the dorsal root ganglion at C2, 
and microganglia of large vessels (Gibbons et al 1984; Edvinsson et al 1989). 
Stimulation of these fibers, from the sphenopalatine and otic ganglia, have 
demonstrated significant increases in cortical blood flow independent of 
cerebral metabolic rate (Goadsby 1989). Although it is clear that the pathways 
originating from the various cranial ganglia affect mCBF, their exact role is 
yet unknown. There is evidence suggesting that these fibers may have a 
protective effect under pathologic states such as hypertension, ischemia, or 
seizures (Chien 1985; Koketsu et al 1992; Sakas et al 1989), and that they 




By far the most important mechanism regulating mCBF is auto¬ 
regulation, i.e. the intrinsic ability of an organ to stabilize its perfusion with 
changes in systemic pressure and to adjust perfusion based on metabolic 
demands. Changes in the caliber of vessels are produced by the products of 
metabolism, including pCC>2, pC>2, extracellular H+, and adenosine. 
Vasodilatation occurs with an increase in pCC>2 and adenosine, and a decrease 
in pC>2 and interstitial pH. Vasoconstriction occurs under the opposite 
conditions. The most important of these factors is pCC>2, producing its effect 
mainly by decreasing extracellular pH (Kontos et al 1977). The hydrogen ion 
concentration is extremely important since an increase can lead to a number 
of destructive processes altering neuronal function, including myelin 
breakdown and disruption of interaxonal connections, as well as irreversible 
damage of both glia and neurons (Goldman et al 1989). A build up of 
metabolites occurs with inadequate perfusion, produces an increase in flow, 
and results in increased nutrient delivery and waste removal. Despite 
variations in systemic pressure, a constant cerebral perfusion is maintained 
through two possible mechanisms, one involving vasoactive metabolites and 
the other vessel wall tension. When arterial pressure increases, an initial rise 
in mCBF removes metabolites at a faster rate. This will result in a 
vasoconstriction and return of flow to previous levels. When arterial 
pressure falls these metabolites are allowed to build up producing 
vasodilatation, and flow increases (Chien 1985; Guyton 1986). The second 
mechanism involves changes in vessel wall stretch, which are determined by 
transmural pressure. When pressure increases the elastic elements of arterial 
walls will stretch and produce a reflex contraction. The action of smooth 
muscle cells will increase the active tension and maintain a stable vascular 
resistance. With low pressure the amount of stretch decreases, the elastic 
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elements relax, and the smooth muscle cells also relax. This is known as the 
myogenic reflex. At present it is unknown which of these two mechanisms 
predominates in autoregulation, however both are likely to be involved 
(Guyton 1986). 
The factors determining mCBF insure that the delivery of nutrients 
meets the brain's high metabolic requirements, and excessive flow is avoided. 
These mechanisms control the large volume of blood delivered to the brain, 
however both metabolic factors and neuronal innervation have also been 
implicated as agents coupling the small volume changes associated with the 
coupling of rCBF to neuronal activity. 
ii. Regulation of rCBF 
While the mechanisms regulating mCBF are suited to determine the 
perfusion of the brain as a single entity, there are two factors which 
necessitate a more precise control at the level of functional neuron groups. 
Neurons have virtually no capacity for anaerobic metabolism and contain 
very limited fuel reserves (Morris and Phil 1989; Plum 1983). In order to 
increase activity there must be an increase in the delivery of nutrients. In 
addition, given the heterogeneity of activity in the brain, it is essential that 
there be a form of regulation allowing local groups of neurons to increase 
their specific blood supply without affecting the blood flow to other regions. 
This type of regulation was postulated by Roy and Sherrington over one 
hundred years ago. 
Utilizing the methods previously described the existence of a 
relationship between rCBF and neuronal activity has been demonstrated 
through a multitude of studies. Using autoradiographic techniques, retinal 




specific regions of the central visual pathways (Sokoloff 1961). A 
heterogeneous change in human cortical blood flow was demonstrated using 
the 133xenon washout method during a motor task. Individuals were 
motivated to open and close one hand while the contralateral cerebral 
hemisphere was monitored for blood flow changes. A 54% mean increase in 
the contralateral hemisphere was observed in nine out of ten subjects. In all, 
the hand area within the motor cortex was identified (Olesen 1971). In 1980 
Roland was able to uncover the role of the supplemental motor cortex in 
motor task initiation by observing changes in rCBF. Subjects were asked to 
mentally rehearse a task but not carry it out. Increases in rCBF were observed 
to occur only in the supplemental motor cortex (Roland et al 1980). 
Advancement of autoradiographic techniques which correlate glucose 
utilization with cerebral activity, the [l^Q-deoxyglucose method (Sokoloff 
1977), definitively established the relationship between local cerebral activity, 
energy metabolism, and rCBF. Combined with [l^cj-iodoantipyrine method 
to measure blood flow (Sakurada et al 1978), identical areas of increased 
metabolism and rCBF were demonstrated during focal seizures in the 
monkey motor cortex (Sokoloff 1981). Studies have also shown the opposite 
effects on metabolism and rCBF with decreases in functional activity. Visual 
deprivation of rats, produced by enucleation of one eye, resulted in unilateral 
decreases in both energy metabolism and rCBF in the lateral geniculate body, 
superior colliculus, and visual cortex, areas of expected decreased activity 
(Sokoloff 1981). 
The specificity of the increased rCBF response has also been 
demonstrated. Using autoradiographic techniques the increase in rCBF 
during rat whisker vibrissal stimulation was limited to a cylinder of tissue 
from 375 pm to 500 pm in diameter (Greenberg et al 1979). The types of 
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vessels affected include the intraparenchymal vessels and the upstream 
resistance vessels supplying them. Excluded from the response were the 
parent vessels which distribute blood to additional areas (Ngai et al 1988). 
These are just a few of the studies which have convincingly 
demonstrated that increased activity of discrete neuronal populations can 
specifically alter their own blood flow. What remains to be identified are the 
mechanisms of this coupling. Roy and Sherrington originally proposed that 
chemical products of metabolism would diffuse in the interstitial fluid and 
produce vasodilatation. In particular they implicated the acidic products of 
metabolism. Since that time this group has grown to include the molecules 
CO2 and adenosine. 
With direct application of CO2 to cat cortex, pial vessels were shown to 
dilate. Antagonism of the dilatation was produced with the addition of 
acetazolamide, a carbonic anhydrase inhibitor. This enzyme is responsible for 
the formation of carbonic acid from CO2 and H2O. Thus the results from this 
study indicate that decreasing pH will promote vasodilatation (Gotoh et al 
1961). The opposite effect was identified in patients with organic dementia. 
These individuals had a reduction in mCBF of 25%-30% which correlated 
with a significant increase in the interstitial pH when compared to normal 
controls (Skinhoj 1966). Formation of organic acids, such as the development 
of lactic acidosis during tissue hypoxia, also produces an increases in rCBF 
(Kogure et al 1970). The effects of a decreased interstitial pH are confined to 
the perivascular space since intravascular injection of a low pH solution does 
not produce a change in flow unless the blood brain barrier is traversed 
(Lassen 1966). These are just a few of the earlier studies demonstrating the 
local vasodilatation produced by decreasing pH. 
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A decrease in interstitial pH is endogenously produced through two 
separate metabolic pathways. The first is direct release of lactic acid during 
anaerobic glycolysis. The second is the conversion of C02, released from the 
citric acid cycle, into carbonic acid by the enzyme carbonic anhydrase. Since 
neurons rely so heavily on oxidative phosphorylation, CO2 is the main 
mechanism of decreasing extracellular pH (Gotoh et al 1961; Kontos 1977). 
How an increase in the extracellular concentration of H+ produces 
vasodilatation is unknown, but it is thought to occur by blocking the Ca+2 
conductance of vascular smooth muscle (Silverberg 1989). More recent 
evidence also suggests that CO2 may have the ability to increase rCBF 
independent of pH (Aubineau et al 1989). 
Although a decrease in extracellular pH is known to alter rCBF, there is 
substantial evidence which indicates that this is not the only factor 
responsible and that it cannot initiate the increase of rCBF to neuronal 
activation. In certain instances of seizure and hypoxia an increase in rCBF 
occurs without a change and occasionally an increase in extracellular pH 
(Astrup et al 1978). More significant are studies which compare the timing of 
increased rCBF with decreases in extracellular pH. Increases in rCBF occur 
immediately with increased activity, yet a significant time delay of five to ten 
seconds occurs before a decrease in extracellular pH is observed (Leniger- 
Follert 1984). Due to this time difference, the decrease in extracellular pH 
could not act as the primary coupling agent between neuronal activity and 
rCBF. This does not mean that extracellular pH is not involved with 
increased rCBF during activity. It is clear that this decrease in pH will increase 
rCBF, but the effect is more likely to be ancillary, helping to maintain flow 
during periods of sustained activity. 
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Tissue oxygen levels, specifically the decrease associated with increased 
metabolism, have also been suggested as a coupling agent. Earlier studies 
hypothesized an initial tissue hypoxia occurring during the onset of neuronal 
activity would produce vasodilatation (Ingvar et al 1962; Caspers and 
Speckmann 1972). What many of these studies failed to do was to separate 
the effect of the decreased tissue oxygen from the production of other 
vasodilating metabolites. Recent investigations do not support these earlier 
assumptions and actually demonstrate an increase in tissue pC>2 at the onset 
of increased activity (Silver 1978; Leniger-Follert and Lubbers 1976; Leniger- 
Follert 1984). Advancement of magnetic resonance imaging techniques, 
which monitor tissue levels of deoxyhemoglobin, have also demonstrated a 
hyperoxia during increased neuronal activity (Ogawa et al 1992; Shulman et al 
1993). Based on these studies it would seem that there is no initial hypoxia 
produced, and in fact an immediate excess of available oxygen occurs with 
increased activity. 
Adenosine's role is more complex than the other products of 
metabolism, since adenosine may also produce vasodilatation as a 
neurotransmitter. Adenosine is known to produce vasodilatation in a 
number of vascular beds, including the cerebral circulation (Burnstock 1990; 
Morii et al 1986; and Ibayashi et al 1991). This vasodilatation is mediated by 
binding to the surface P2 purinergic receptor (Burnstock 1990; Olsson and 
Pearson 1990; Ngai and Winn 1993). This receptor complex is coupled to a 
GTP binding protein (Torregrosa et al 1990; Hardebo et al 1987), which 
activates phospholipase C and increases intracellular concentrations of 
inositol 1,4,5-triphosphate and Ca+2 (Forsberg et al 1987; Brock et al 1988; 
Carter et al 1989). Such receptors have been identified throughout the 
cerebral vascular tree (Edvinsson and Fredholm 1983; Hardebo et al 1987; 
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Ibayashi et al 1991). Their action has been localized to the extraluminal side of 
cerebral vessels indicating that the mechanism of adenosine vasodilatation is 
endothelium independent (Ngai and Winn 1993). 
The exact role adenosine plays in the coupling of rCBF to neuronal 
activity is controversial. During bicuculline induced seizures both rCBF and 
adenosine concentrations have been shown to increase (Winn et al 1980). 
Studies using adenosine deaminase, an antagonist of the adenosine mediated 
vasodilatation, have shown conflicting results. A heightened response of 
rCBF to anoxia has been shown with adenosine deaminase inhibitors (Phillis 
et al 1985), however direct application of adenosine deaminase did not block 
the response of rCBF with hypoxia or electrical stimulation (Dora et al 1980). 
With sciatic nerve stimulation the response of rCBF in the somatosensory 
cortex has been manipulated by substances which affect adenosine availability 
(Ko et al 1990), however application of 8-(p-sulfophenyl) theophylline 
(8-THEO), an antagonist of purinergic receptors, did not attenuate the increase 
in rCBF (Northington et al 1992). During brain ischemia adenosine increases 
by two fold within five seconds (Winn et al 1985), however this concentration 
increase has only a marginal affect on pial vascular resistance (Wahl and 
Kuschinsky 1977). These conflicting results do not remove adenosine as a 
possible agent in this coupling, but instead demonstrate that other factors 
must be involved. 
Another consideration is the source of adenosine release. As stated 
earlier adenosine can be released as a metabolic by-product and as a 
neurotransmitter. Dephosphorylation of adenosine monophosphate during 
metabolism results in increased extracellular concentration of adenosine 
(Rubio et al 1975). An important factor which supports adenosine's role as a 
neurotransmitter instead of a product of metabolism is the time delay 
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between build up of metabolic factors and increase in rCBF. Adenosine and 
adenosine nucleotides have been identified in a number of nerve terminals 
which innervate blood vessels (Burnstock 1990). Adenosine triphosphate 
(ATP) has been localized in various neurons and is thought to act as a co¬ 
transmitter. The extracellular breakdown of ATP may serve as one source of 
adenosine release (Richardson et al 1987; Pelleg and Burnstock 1990). In 
addition adenosine is directly released from neurons during depolarization 
(Phillis and Wu 1981; Bender et al 1981; Jonzon and Fredholm 1985; During 
and Spencer 1992). As discussed below, neurotransmitters are the most likely 
agents to couple rCBF to neuronal activity. Considering this evidence 
adenosine is capable of acting as the coupling agent but at least one other 
compound must be involved. 
A final consideration which does not support the hypothesis that 
metabolic factors are the direct link between rCBF and neuronal activity is 
their disproportionate increases. This has been shown at the neuronal (Silver 
1978) as well as regional level (Nilsson et al 1978). During periods of intense 
activity, e.g. hyperthermia and status epilepticus, the increase in blood flow is 
much greater than the metabolic requirements of activated tissue (Nilsson et 
al 1978). This discrepancy is not limited to pathological conditions, but also 
occurs with physiological activation. During finger vibration stimulation the 
contralateral somatosensory cortex demonstrated an increase in rCBF of 29% 
while there was only a 5% increase in the regional cerebral metabolic rate of 
C>2 consumption (rCMRC>2). In addition a decline of 02 extraction of 20% 
occurred. This discrepancy could not be explained by a transient overshoot of 
rCBF or a time delay in the rCMRC>2 increase (Fox and Raichle 1986). 
Based on the evidence presented, several assumptions can be made in 
regards to the role which metabolic by-products may play in the coupling of 
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rCBF to neuronal activity. (1) These agents cannot act as the sole factors 
involved due to the discrepancy between rCBF and metabolic requirements. 
(2) There must be additional factors which initiate the increase in rCBF given 
the time difference between increased flow and the accumulation of 
metabolic factors. (3) These agents do increase rCBF, but most likely act to 
maintain it during sustained activity (Lou et al 1987). 
Since the evidence for metabolic by-products as the regulatory agents of 
rCBF is not convincing, other factors released during neuronal activation 
have been implicated, such as K+. It is well established that during neuronal 
activity the extracellular concentration of potassium increases due to changes 
in the conductance characteristics of the neuronal membrane. K+ has also 
been shown to act as a potent vasodilator (Kuschinsky et al 1972). It therefore 
seemed likely that K+ could act as a link between the increase in rCBF and 
neuronal activity. One problem with this hypothesis was that simple 
diffusion could not distribute the ion in sufficient concentrations over the 
area needed in the short time interval allowed. Astrocytes were hypothesized 
to overcome these spatial and temporal obstacles. K+ ions released in the 
extracellular environment during increased neuronal activity are taken up by 
astrocytes. This uptake depolarizes the cell and causes a K+ efflux, resulting 
in a spatial buffering (Barres et al 1990). The areas of the astrocyte which have 
the greatest conductance for K+ are the astrocytic endfeet which are intimately 
associated with intraparenchymal resistance vessels. Using a computer 
simulation, this effect, known as "K+ siphoning," could produce a sufficient 
concentration in the perivascular space in a shorter time period than simple 
diffusion would accomplish (Paulson and Newman 1987). This hypothesis, 
although very attractive, was not supported by direct experimental evidence. 
Antagonism of astrocytic K+ uptake, with Ba+2, did not attenuate the increase 
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in rCBF which occurs during electrical stimulation (Kraig and Iadecola 1989). 
Other studies have also demonstrated increases of rCBF independent of K+. 
Amphetamine stimulation produces an increase in rCBF without any change 
in extracellular K+ (Berntman et al 1978). K+ ions may play a minor role in 
increasing rCBF however it seems unlikely that K+ could produce the degree 
of increased rCBF observed. 
Given the evidence presented thus far, the mediators suggested, except 
for adenosine, are unlikely to serve as the direct link between neuronal 
activity and rCBF. Instead these compounds are more likely to play an 
accessory role. Due to the spatial and temporal precision needed, direct 
neuronal innervation appears to be the only means by which rCBF may be 
coupled to neuronal activity. Extensive evidence exists which demonstrates 
the intimate relationship between neuron terminals and intraparenchymal 
vessels (Hartman et al 1972; Csillik et al 1971; Rennels and Nelson 1975) 
Three types of neuronal innervation have been hypothesized which may 
provide the necessary coupling agent in this response; fiber pathways 
originating from extrinsic ganglia, fiber pathways originating from 
intracerebral nuclei, and local neurons (Iadecola 1993). 
The extrinsic pathways communicating with cerebral vessels have 
previously been described in mCBF regulation. These fibers originate from 
several extrinsic ganglia including the superior and stellate ganglia, the 
trigeminal ganglion, and the sphenopalatine ganglion. They contain a wide 
variety of neurotransmitters, previously described, which have vasomotor 
effects. These pathways however are not likely to mediate the coupling 
between neuronal activity and rCBF. The vessels which these fiber tracts 
innervate are the large extraparenchymal vessels, which control CBF at a 
gross level. Also studies in which these fiber bundles are interrupted have 
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shown no change in the response of rCBF with local neuronal stimulation 
(Ibayashi et al 1991; Iadecola et al 1993). 
Intrinsic pathways contain many of the same neurotransmitters within 
the fibers of the extrinsic pathways (Iadecola 1993). There are many studies as 
well which demonstrate changes in CBF with stimulation of these pathways. 
Intrinsic adrenergic fibers, from the locus coeruleus, innervate cerebral 
vessels (Swanson et al 1977) and produce changes in microvessel permeability 
and flow with chemical and electrical stimulation (Raichle et al 1976). Fibers 
from the raphe nuclei, releasing 5-hydroxytryptamine (5-HT), innervate 
cerebral microvessels and produce vasodilatation with stimulation 
(Edvinsson et al 1983; Harper and MacKenzie 1977; Reinhard et al 1979). 
Stimulation of cholinergic pathways, from the cerebellar fastigial nucleus 
(Iadecola et al 1987; Nakai et al 1982) and basal forebrain (Arneric 1989), 
produces a global increase in cortical flow. It is obvious that such pathways 
can influence large areas of rCBF, however there is considerable evidence 
which indicates that these pathways are not the main mechanism coupling 
spatially discrete increases in rCBF. Lesions and pharmacological blockade of 
the cholinergic fibers does not hamper the effect of somatosensory 
stimulation on rCBF (Ibayashi et al 1991). Local release of VIP through 
stimulation of the reticular formation and cortex may participate in local 
cortical increases in blood flow, however a significant portion of this response 
is independent of VIP (Yaksh et al 1987; Iadecola 1993). The locus coeruleus is 
thought to affect rCBF responses to cortical stimulation through an effect on 
oxidative metabolism (LaManna et al 1981; Iadecola 1993). Given this 
information and the diffuse innervation of these intrinsic pathways, a more 
likely mechanism of their action is to regulate mCBF instead of acting as a 
direct link between discrete areas of activation and increases in rCBF. 
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Since both extrinsic and intrinsic pathways are not likely to provide a 
neurotransmitter coupling neuronal activity to rCBF, the only other source 
would be release from locally activated neurons. In order for local neurons to 
produce an increase in their own blood supply, the transmitter released 
should fulfill several requirements. First this substance should be a 
ubiquitous substance produced by a wide variety of neurons throughout the 
brain. Its release must occur at the onset of increased neuronal activity. It 
should be locally diffusable so as to have easy access to the perivascular space 
and produce significant vasodilatation. Finally such a transmitter's 
production must be tightly controlled and undergo rapid inactivation so that 
neurons may fine tune rCBF to transient changes in their activity. Recently 
one substance has been shown to produce a wide variety of effects within the 
body, including the coupling of rCBF to neuronal activity. This molecule is 
Nitric Oxide (NO). 
D.) Nitric Oxide: the Mediator Regulating rCBF 
NO possesses an extremely simple molecular formula, however over 
the last few years a number of very important and increasingly complex 
physiological functions have been hypothesized for it (Snyder and Bredt 
1992). NO is thought to be the agent responsible for the cytotoxic effects of 
macrophages (Guoyao and Brosnan 1992; Stuehr and Nathan 1989), a factor in 
the production of long term potentiation (Haley et al 1992), responsible for the 
neurotoxicity induced by excitatory amino acids (Dawson et al 1991), and 
implicated as the first in a novel class of neurotransmitters (Bredt and Snyder 
1992; Dawson et al 1992). 
NO is produced by the enzyme nitric oxide synthase (NOS). Several 
different isoforms of this enzyme exist; an inducible cystolic enzyme within 
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macrophages, a membrane-bound constitutive isoform within endothelial 
cells, and a constitutive cystolic enzyme within neurons. The constitutive 
isoforms requires a Ca+2/calmodulin co-factor and continually produce NO 
(Fostermann et al 1991). Despite different locations these enzymes produce 
NO through the same basic reaction. The terminal guanidino nitrogen atom 
from the endogenous amino acid L-arginine is oxidized, producing NO and 
the amino acid citrulline in a one to one molar ratio (Leone et al 1991;White 
and Marietta 1992; Bush et al 1992). NOS has been localized throughout the 
central nervous system , with high concentrations in the cerebellum and 
dentate gyrus of the hippocampus (Bredt et al 1990). Terminals of NOS 
containing neurons have recently been shown to exist in close apposition to 
intra-parenchymal vessels within the hippocampus (Nwai 1993). 
NO is produced during neuronal activation by an influx of 
extracellular Ca+2 through an ionotropic glutamate receptor, the N-methyl-D- 
aspartate (NMDA) receptor (Kiedrowski et al 1992). Although activation of 
NOS is primarily thought to occur through this receptor, other glutamate 
receptors have also been shown to increase NO production (Okada 1992). The 
Ca+2 which enters the neuron binds to the co-factor calmodulin and activates 
NOS. NO's release with neuronal activation has lead to the hypothesis that 
NO is the first in a novel class of neuro-transmitters . Unlike the classical 
neurotransmitters, nitric oxide is produced on demand, is not stored in 
vesicles, is released by simple diffusion across the cell membrane, and 
interacts with an intracellular receptor, the enzyme guanylyl cyclase (Snyder 
and Bredt 1992; Dawson et al 1992). NO activates this enzyme by binding to 
the heme moiety and increases the intracellular concentration of cyclic 
guanosine monophosphate (cGMP) (Schmidt 1992; Bredt and Snyder 1989). 
This increase in cGMP activates the second messenger system and produces 
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various effects, one of which is vascular smooth muscle relaxation and 
vasodilatation (Gold et al 1990). NO's ability to act as a vasodilating substance 
was proven when it was identified as endothelial derived relaxing factor 
(EDRF) (Palmer et al 1987). The exact mechanism of cGMP vasodilatation is 
unknown, however two possibilities that have been proposed include a 
decrease in intracellular Ca+2, or a hyperpolarization of the smooth muscle 
mediated through an ATP sensitive K+ channel (Iadecola 1993). The half-life 
of NO is extremely short, in the order of seconds. NO is converted into the 
more stable nitroso products including NO2 and NO3 (Snyder and Bredt 
1992). There has also been a mechanism proposed in which NO modulates its 
own production through a negative feedback loop (Rogers and Ignarro 1992). 
Given these characteristics it is clear why NO has become the candidate 
of choice to couple rCBF to neuronal activity. NO is a powerful vasodilator, is 
released with neuronal activation, is widely distributed throughout the 
central nervous system, is locally diffusable, and its production is strictly 
regulated. All these abilities point to NO as the missing link between rCBF 
and neuronal activity. However, given the complexity of this relationship it 
is unlikely that NO is the sole coupling agent. Mediators traditionally 
hypothesized, such as adenosine and other neurotransmitters, may still 
contribute to this response. 
E. Specific Aims 
To identify possible mediators coupling rCBF to neuronal activity the 
novel combination of intracerebral microdialysis with LDF is applied to the 
rat CA-1 /dentate hilus region in the hippocampus. By simultaneously 
applying these techniques changes in rCBF can be correlated to the release of 
possible regulatory factors in the extracellular fluid. In addition the use of 
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microdialysis will enable the local application of pharmacological agents 
without inducing other flow regulating tissues. 
Neuronal activation is increased by infusing the glutamate receptor 
agonist, NMDA. Microdialysis samples will be analyzed for citrulline and 
adenosine release. Since NO is degraded so quickly the more stable by¬ 
product, citrulline, is measured as an index of NO synthesis. The effect of NO 
on rCBF will be determined by the direct application of NO within the 
interstitium. Inhibitors to NO synthesis will demonstrate that the increase in 
rCBF with neuronal activation is in part dependent on NO production. An 
antagonist of the P2 purinergic receptor will demonstrate that this response is 
not entirely NO dependent but also requires the release of adenosine. Finally 
to determine whether the response of rCBF occurs under a normal 
physiologic stimulus, the endogenous excitatory pathway to the 
hippocampus, the perforant pathway, will be electrically stimulated and 
changes in rCBF observed. 
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MATERIALS AND METHODS 
A. ) Materials 
Laser doppler flowmeter and accessories were provided by Perimed, 
Inc. (Piscataway, N.J.). Dialysis membrane was made of cuprophan-treated, 
regenerated cellulose with a molecular weight cutoff of 5000 daltons 
(Glanstoff Inc., Germany). Silica tubing was obtained from Polymicro 
Technologies Inc. (Phoenix, Az.). Polyethylene tubing, PE-60, was obtained 
from Clay Adams (Parsippany, N.J.). Guide cannulae and brass nuts were 
manufactured by Plastic One Inc. (Roanoke, VA.). NMDA and L-arginine 
were obtained from Sigma (St. Louis, M.O.). NG-nitro-L-arginine methyl ester 
(NAME), S-nitroso-N-acetylpenicillamin (SNAP), and 8-(p-sulfophenyl) 
theophylline (8-THEO) were obtained from Research Biochemicals 
International (Natick, MA). 
B. ) Microdialysis Probe Construction 
The microdialysis probe constructed was modified from a previous 
design developed by Dr. Matthew J. During (During and Spencer 1991). Silica 
tubing was used to construct the inlet and outlet of the microdialysis probe. 
Inlet tubing (ID 76 pm) was cut to 60 mm and outlet tubing (ID 97 pm) was cut 
to 62.0 mm. A 0.5 inch 23 gauge stainless steel connector was fastened to each 
with epoxy. Dialysis membrane was cut to 
15.0 mm and sealed at one end with an epoxy plug, less than 1 mm in length. 
The outlet of the probe was inserted into the membrane and placed flush 
against the epoxy plug. The inlet was inserted and positioned 2.0 mm short of 
the epoxy plug, thereby producing a 2.0 mm distance of "active" dialysis 
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membrane. The proximal end of the dialysis membrane was sealed to the 
inlet and outlet silica tubing with polyacrylamide. A length of 15.0 mm along 
the probe was measured from the tip of the outlet. One end of PE-60 tubing 
was splayed by heating while the straight end was inserted through a brass 
nut. The tubing was cut so that the distal 15.0 mm of the probe extended 
beyond the splayed end. The brass nut was then used to fasten the probe to 
the guide cannulae. The probe was inserted through the PE-60 tubing and the 
23 gauge metal leads were fastened to the straight end of the tubing with 
epoxy. An epoxy plug was then applied to the splayed end at the 15.0 mm 
mark, so this distance of the probe remained exposed. This plug prevents the 
probe from extending beyond the proper depth once inserted through a 
13.0 mm guide cannula. Therefore 2.0 mm of the exposed dialysis membrane 
lies within brain parenchyma. 
C. ) Guide Cannulae Preparation 
Synthetic guide cannulae were cut to 13 mm in length. Stylets were cut 
so that 2.0 mm and 1.7 mm would exit the microdialysis and laser doppler 
guide cannulae respectively upon insertion. These stylets were inserted at the 
time of initial surgery to prepare the neuronal tissue for subsequent 
occupation by the microdialysis and laser doppler probes. This significantly 
reduces the amount of tissue trauma induced with the subsequent placement 
of these probes (Devine et al. 1993). 
D. ) Animal Preparation 
Male Sprague-Dawley rats (250-350 gms) were anesthetized with a 
solution of Ketamine/Xylazine (8/80mg per kg) intraperitoneally (IP). 
Animals underwent stereotaxic surgery for unilateral placement of paired 
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guide cannulae, through which the microdialysis and laser doppler probes 
would be placed into the CAl-dentate hilus of the hippocampus. The 
coordinates for the microdialysis guide cannula were 4.3 mm posterior and 
2.0 mm lateral from bregma, and the coordinates for the laser doppler guide 
cannula were 4.3 mm posterior and 4.5 mm lateral from bregma (Paxinos and 
Watson, 1986). The microdialysis guide was inserted at 0.0 degrees from the 
vertical and 2.0 mm deep from the outer table of the rats skull. The laser 
doppler guide was inserted at +32.0 degrees from the vertical and 2.0 mm 
deep from the skull's outer table. Four skull screws were embedded around 
the guide cannulae coordinates. The guide cannulae were then placed and 
initially held into position with polyacrylamide. Dental adhesive was then 
applied around both the skull screws and guide cannulae, the screws 
anchoring the dental adhesive to the skull. Stylets were inserted through the 
guide cannulae and extended to the approximate depth of both the 
microdialysis and laser doppler probes. Animals were allowed to recover for 
6 to 9 days. Approximately 24 hours before the experiment a microdialysis 
probe was inserted through the guide cannula to a depth predetermined from 
the probes construction. 
E.) Experimental Protocols 
i. Baseline Protocol 
Animals were initially anesthetized with a loading dose of a- 
chloralose/urethane solution, 0.075 and 0.75 gm/kg IP respectively. 
Anesthesia was maintained with intermittent IP injections of a- 
chloralose/urethane, approximately 0.015 and 0.15 mg/kg/hr. A heating pad 
was used to maintain the axillary temperature of the animal at 38.0 + 1.0 
degree Celsius. Animals were placed in the stereotaxic frame to ensure head 
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stability, a requirement for movement artifact-free laser doppler 
measurements. The entire stereotaxic frame was then placed into a sand bin 
on top of three tennis balls which acted as a simplified vibration table. This 
eliminated any tissue movement in relation to the laser doppler probe 
produced by surrounding vibrations, also ensuring movement artifact-free 
measurements. A stainless steel laser doppler light guide, outer diameter of 
450 pM, was inserted through its guide cannula and extended to a depth of 
1.64 mm beyond the guide, into the dorsal CAl-dentate hilus of the 
hippocampus. This would place the laser doppler probe within 1.0 mm of the 
microdialysis probe membrane. Figure la. is a schematic representation of 
the probe placement, and figure lb. is a sectioned brain showing the paths 
produced by both probes and demonstrating their close proximity within the 
CA1 /dentate gyrus. Such close proximity is necessary in order for the laser 
doppler, with a measuring volume of approximately 2.0 mm^, to monitor the 
area influenced by the microdialysis probe. An artificial extracellular fluid 
(ECF), made up of 135 mM NaCl, 3.0 mM KC1, 1.0 mM MgS04,1.2 mM 
Ca2CF2H20, and 2.0 mM Na2HP04/NaH2P04 to pH 7.4, was infused through 
the microdialysis probe at a rate of 2.5 ml per minute. All pharmacological 
agents infused were mixed in this artificial ECF and given over 30 minute 
intervals. Microdialysis samples were collected for these 30 minute time 
periods into microcentrifuge tubes and stored on ice. A baseline of 1.5 hours 
was obtained for both laser doppler and microdialysis prior to protocol 
initiation. Changes in rCBF were represented as percents of baseline, 
accounting for both the increased amplitude as well as the duration of 
responses. Microdialysis samples were analyzed for both adenosine and 
citrulline with HPLC. Once a baseline was established animals underwent 
one of several experimental protocols. 
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ii. Response of rCBF to NMDA 
Each animal received sequentially increasing concentrations of NMDA 
at 50, 100, 200, and 500 jiM, for 30 minute intervals, to determine if rCBF 
would respond to neuronal stimulation in a dose dependent manner (n=10). 
Between each stimulation period there was a washout of 60 minutes with 
artificial ECF to establish a new baseline. Microdialysis samples were 
analyzed for both citrulline, an indirect index of NO production, and 
adenosine production. 
Within this experimental group four animals underwent the protocol 
with both arterial and venous catheters placed in femoral vessels. The 
arterial line was used to measure systemic blood pressure prior to and during 
the time of NMDA stimulation (n=4). Arterial blood was drawn at the 
commencement of the study, just prior to, and 15 minutes into the 500 |iM 
NMDA dose to measure p02, pC02, pH, and hematocrit (n=3). This group 
served as a control to insure that the systemic parameters did not change 
during local pharmacological manipulation. 
A second group of animals received sequential doses of 200 mM 
NMDA (n=4) to determine whether repeated doses of NMDA produced either 
a facilitating or desensitizing effect in the response of rCBF to NMDA. 
iii. Response of rCBF to NO 
After a baseline was established animals were infused with the direct 
NO donor S-nitroso-N-acetylpenicillamine (SNAP) at a concentration of 1 
mM (n=6). Microdialysis samples were not analyzed. 
iv. Response of rCBF to NOS Inhibition 
Using the competitive NOS inhibitor, NG-nitro-L-arginine methyl ester 
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(NAME), the response of basal and NMDA induced rCBF were observed 
during decreased production of NO. After the initial baseline a 200 pM dose 
of NMDA was administered. A baseline was re-established with artificial ECF 
over a 60 minute time interval. NAME was then infused, at 5 mM, alone to 
observe the effects of NOS inhibition on basal blood flow. After this period 
both 5mM NAME and 200 pM NMDA were given together to observe if NOS 
inhibition would attenuate the response of rCBF to NMDA stimulation. 
Microdialysis samples were analyzed for citrulline release (n=8). 
Reversal of this inhibition was attempted by simultaneously infusing 
the endogenous substrate L-arginine with NAME. The effects of excessive 
endogenous substrate alone were also observed. Animals were initially 
infused with 100 mM L-arginine, and then immediately with a combination 
of both 100 mM L-arginine and 5 mM NAME (n=6). Microdialysis samples 
could not be analyzed since the excessive amounts of L-arginine consumed 
the derivatizing agents used during HPLC analysis. 
v. Response of rCBF to P2 Receptor Blockade 
The effects on both basal and NMDA stimulated flow were observed 
during blockade of the purinergic receptors with the use of a methyl-xanthine 
derivative, 8-(p-sulfophenyl) theophylline (8-THEO) (Ngai and Winn 1993). 
After a stable baseline, 200 pM NMDA was infused through the microdialysis 
probe. A baseline was re-established with artificial ECF for 60 minutes. Then 
500 pM 8-THEO was administered alone, followed immediately with a 
combination of 200 pM NMDA and 500 pM 8-THEO (n=5). Microdialysis 
samples were not analyzed for the release of adenosine, since the release of 
adenosine with NMDA stimulation was demonstrated in the initial protocol. 
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vi. Response of rCBF to Perforant Pathway Stimulation 
To determine whether an increase in hippocampus rCBF would occur 
with synaptic excitation, the perforant pathway was electrically stimulated 
with a bipolar electrode. Animals were prepared as in all other groups except 
a bipolar electrode was inserted into the perforant pathway on the same side 
as the microdialysis and LDF probes. The electrode was inserted at the 
following coordinates, 8.4 mm posterior and 4.0 mm lateral to Bregma, to a 
depth of 4.8 mm at 0.0 degrees from the skull surface. After a baseline was 
established the animal received two stimulation paradigms. The first was a 2 
volt stimulus, at frequency of 2Hz , for a 0.1 msec duration, and a total 
stimulus time of 20 seconds. After an equilibration period, the same 
paradigm was used except the voltage was increased to 5.0 volts. 
Microdialysis samples were collected over 5.0 minute intervals before, during, 
and after the stimuli. 
F.) HPLC Methods 
1.) Citrulline Method 
Citrulline was analyzed using gradient HPLC with fluorescence 
detection and pre-column derivatization with o-phthaldialdehyde (OPA). 
The derivatizing stock solution was made monthly and kept at -20 degrees 
Celsius. The stock reagent consisted of 10 mg OPA, 25 ml beta- 
mercaptoethanol (BME), 0.5 ml of 50mM (pH=9.5) borate buffer, and 4.5 ml 
methanol. The working derivatizing reagent was freshly made daily and was 
a mixture of 100 ml of methanol, 100 ml of 50 inM (pH=9.5) sodium borate 
buffer, and 36 ml of OPA/BME stock solution, which was thoroughly 
vortexed. The HPLC consisted of dual Gilson (Westwood, New Jersey) 306 
HPLC dual pumps, a 811C Dynamic mixer and 805 Manometric Module, and a 
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Shimadzu (Kyoto, Japan) RF-551 fluorometric detector (excitation of 330 nm 
and emission of 440 nm). Mobile phase A was a 0.03 M sodium acetate, 1.0% 
tetrahydrofuran solution (pH=6.88) and mobile phase B was a 0.1M sodium 
acetate, 80.0% acetonitrile solution (pH=6.82). Sample volumes of 5.0 ml were 
mixed with 3.0 ml of reagent with a reaction time of 60 seconds. A total 
volume of 7.5 ml was then injected onto a 2.0 X 150 3.0 mm ODS Hypersil 
HPLC column (Keystone Scientific, Bellefonte, PA). At the onset of sampling 
the percentages of the two mobile phases was 89.5% A and 10.5% B for the 
first 14.0 minutes. The percent of mobile phase B was then increased at a rate 
of 2.0 % per minute for the next 4.0 minutes with final concentrations of 81.5 
% mobile phase A and 18.5% mobile phase B. The total run time was 22.0 
minutes. The column was then flushed with 0.5% A and 95.0% B for a total 
of 1.5 minutes, with an 8 minute equilibration time. 
ii. Adenosine Method 
An HPLC system with ultraviolet detection was used for quantification 
of adenosine. A BAS200A (BAS, Inc., West Lafayette, IN) system was used 
isocratically with the mobile phase consisting of 10 mM NaH2P04 (pH=4.5) 
with 5% CH3CN (vol/vol.) pumped at 0.8 ml/min. The column used to 
achieve separation was a 3.2 xlO-cm, 3mm Phase-II ODS column (BAS, Inc). 
The ultraviolet detector was set at 0.0005 AUFS (absorbance units full scale). 
Adenosine eluted within 8 minutes and peak heights recorded on a strip 
chart recorder were compared with external standards for quantification. 
G.) Statistical Methods 
The raw data was log transformed and the overall significance of 
treatment groups was determined using repeated measures ANOVA. Post 
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hoc differences between individual treatment groups were determined using 
Student Paired T Tests. Data is represented as mean + standard error of the 
mean, (SEM). 
Investigation designs, material constructions, experimental protocols, 





A. ) Baseline 
Upon insertion of the laser doppler probe into the rat hippocampus, a 
30 minute time interval was allowed before baseline measurements were 
attempted. The recordings of the laser doppler were observed to be stable 
over an initial baseline period of 90 minutes. The LDF results are displayed as 
percent of baseline since blood flow is reported in arbitrary units which 
cannot be converted into quantitative values (Dirnagl et al. 1989). Onset of 
microdialysis flow did not produce any change in the laser doppler readings. 
Data from microdialysis samples are normalized to a baseline of 100% and 
represented as a percent change from this baseline. 
B. ) Response of rCBF to NMDA 
The responses of rCBF to increasing concentrations of NMDA are 
summarized in figure 2. As evident from figure 2 there is a dose dependence 
of rCBF to NMDA stimulation. The increases were 106.8 +2.3%, 120.0 ±6.3%, 
148.0 ± 16.6%, and 191.1 ±20.4% of baseline at 50 |iM, 100 pM, 200 pM, and 500 
pM NMDA respectively. An example of the actual recordings from the laser 
doppler is shown in figure 3. The data are displayed in trace pairs; the top 
trace of each pair is equal to the blood flow, and the lower trace represents the 
concentration of moving blood cells. Flow is determined from two variables, 
the velocity and the concentration of moving red blood cells. For a more 
detailed description see appendix IA. Each response proved to be statistically 
significant when compared to baseline values as well as when compared to 
the preceding response (p<0.05). 
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In the group receiving two sequential doses of 200 pM NMDA, no 
statistically significant difference between the responses occurred (p=0.57). 
The first response produced an increase of 21.7+4.7%, and the second response 
produced an increase of 24.9+6.7%. 
Table I. reports the physiological data obtained from the group of 
animals which received sequentially increasing doses of NMDA while 
systemic parameters were monitored. Although there is a tendency for both 
blood pressure and arterial oxygen to fall during the course of the experiment 
(7 hours), the infusion of NMDA did not produce any change in any of the 
physiologic parameters. There was also no change in blood pressure during 
the infusions of 50 pM, 100 pM, and 200 pM NMDA, data not shown. 
The responses of citrulline and adenosine are shown in Figure 4a & 4b 
respectively. The increases in citrulline at 50 pM, 100 pM, 200 pM, and 500 
pM NMDA were 128.9±7.4%, 141.2±15.4%, 147.2±20.4%, and 196.8±22.3% of 
baseline. The increases in adenosine at 50 pM, 100 pM, 200 pM, and 500 pM 
NMDA were 355.9±112.7%, 1233.5±509.2%, 833.9±378.5%, and 1270.2±958.3% 
of baseline. During stimulation periods these increases proved to be 
statistically significant from baseline (p<0.05). Although there is a tendency 
towards larger increases of citrulline and adenosine with increasing doses of 
NMDA, a dose dependent response did not prove to be significant (p>0.10). 
C.) Response of rCBF to NO 
Direct administration of NO was achieved with the infusion of SNAP. 
Figure 5 shows the effects of 1 mM SNAP on rCBF, which increased to 
137.0+5.8% of baseline (n=6). This increase proved to be a statistically 
significant increase from baseline values (p<0.05). 
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D.) Response of rCBF to NOS Inhibition 
The effects of the NOS inhibitor, NAME, were determined for both 
basal and NMDA stimulated rCBF. Figure 6 shows the decrease produced 
with the infusion of 5 mM NAME during both parameters. When 5 mM 
NAME was given alone there was a decrease in rCBF to 77.0±3.0% of baseline 
(n=9). After a re-equilibration period 200 |iM NMDA was given alone and 
produced an increase to 160.4+9.2% of basal flow. This response was 
decreased but not abolished with co-administration of 5 mM NAME to 
125.0±6.6% of baseline, which represents a 56.6±10.0% decrease in the 
response (n=6). The decreases produced by 5 mM NAME from both basal and 
NMDA induced flow were statistically significant (p<0.05). Microdialysis 
samples were analyzed to determine if extracellular concentrations of 
citrulline would decrease with NOS inhibition, see figure 7. During 
administration of 5 mM NAME alone there was a decrease in extracellular 
levels of citrulline to 64.1+5.9% of baseline values. Citrulline levels increased 
to 134.1+4.4% of baseline during 200 pM NMDA administration. This 
increase was blocked when 5 mM NAME was given in combination with 
NMDA, to a value almost identical to when NAME was given alone, 
67.6+9.2% baseline. Statistically significant differences occurred between the 
decreases in citrulline with 5 mM NAME when compared to both baseline 
and NMDA induced levels of extracellular citrulline (p<0.05).There was no 
significance between the two values of citrulline during NAME infusion 
(p>0.10) 
The results obtained with infusion of excessive endogenous substrate 
alone and with 5 mM NAME are represented in Figure 8. When 100 mM L- 
arginine is given alone there was an increase of rCBF to 113.3±2.9% of 
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baseline flow. As shown previously the decrease in rCBF produced by 5 mM 
NAME was 77.0+3.0% of basal flow. This decrease is antagonized when 
100 mM L-arginine is given in combination with 5 mM NAME to 92.6+2.2% 
of basal flow. The increase from basal flow and the attenuation of the 5 mM 
NAME response produced with 100 mM L-arginine were statistically 
significant (p<0.05). Microdialysis samples were unable to be analyzed for this 
group. 
E. ) Response of rCBF to P2 Receptor Blockade 
The results obtained with blockade of the adenosine receptors are 
shown in Figure 6, along with the results of NOS inhibition. Antagonism of 
the adenosine receptor was carried out under baseline conditions as well as 
with NMDA stimulated flow. When 500 pM 8-THEO was given alone, rCBF 
was decreased to 74.9+2.0% of baseline (n=7). This decrease was statistically 
significant (p<0.05). In this experimental group the increase produced by 200 
pM NMDA was 138.0+8.0% of baseline. Attenuation, but not obliteration, of 
this response occurred when 500 pM 8-THEO was given in combination with 
200 pM NMDA. The increase in rCBF was only 108.0+3.4% of baseline, 
representing a 78.7+7.8% decrease in the response produced with NMDA 
stimulation alone (n=5). This decrease was statistically significant (p<0.05). 
F. ) Response of rCBF to Perforant Pathway Stimulation 
The effects on rCBF of a synaptic stimulation in the CA1/dentate hilus 
of the rat hippocampus were examined by electrically stimulating the 
perforant pathway with a bipolar electrode. The results are demonstrated in 
Figure 9. There was a clear difference between the two stimulus paradigms, 
with the 5 volt stimuli producing a peak increase in flow of 179+5.4% of 
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baseline and the 2 volt stimulus producing an increase of 122.0+2.8% of 
baseline (n=2). The difference between these response and between the 
responses and baseline proved to be statistically significant (p<0.05). The 
onset of both responses occurred at the same time with stimulation onset, 
however the duration of the 5 volt response is maintained above baseline for 
25 seconds after the stimulus, while the response to 2 volts returns to baseline 




A.) The Combination of LDF and Microdialysis 
The primary goal of this study was to determine whether or not both 
NO and adenosine participate in the coupling of rCBF to local increases in 
neuronal activity. In order to carry out this investigation however, an 
improvement on previously used methods was necessary. Therefore a 
secondary goal was to demonstrate that the novel combination of two existing 
techniques, LDF and microdialysis, would be an effective methodology. The 
primary advantage of using both techniques simultaneously is the ability to 
characterize potential mediators released into the extracellular environment 
while continuously measuring rCBF for sudden changes. In addition, 
microdialysis enables a localized administration of pharmacological agents, 
producing increased neuronal activity, without affecting the release 
vasoactive substances from other tissues. 
The first in vivo laser doppler measurements of blood flow were done 
in 1972 by Riva and colleagues studying the flow of rabbit retinal vessels (Riva 
et al 1972). Since that time the use of laser doppler has expanded to measure 
the microcirculation in a variety of tissues from the skin to the central 
nervous system. The validity of laser doppler has been established through 
the many studies comparing it with other pre-existing techniques which 
monitor local tissue blood flow. These include plethysmography (Johnson et 
al 1984), xenon clearance (Olsson 1986), and transcutaneous oximetry (Allen 
and Goldman 1987). In the central nervous system laser doppler has been 
compared to radionuclide labeled microspheres (Eyre et al 1988), [C^] 
iodoantipyrine measurements (Dirnagl et al 1989), and hydrogen clearance 
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(Haberl et al. 1989), and found to have correlation coefficients of 0.92, 0.91, and 
0.97, respectively. These studies concluded that the laser doppler was best 
suited for continuous measurements of cerebral blood flow in which rapid 
changes were to be observed. It is this ability of the laser doppler, to make 
real-time measurements of blood flow, which gives it an advantage over pre¬ 
existing techniques to investigate the coupling of rCBF to neuronal activity. 
Microdialysis has become the most stabilized technique to sample the 
neuronal extracellular fluid for the release of various transmitters. The 
method has progressed to the point of utilization in the conscious human 
brain (During and Spencer 1992; During and Spencer 1993). The sampling of 
adenosine has been done in a variety of studies, and the method is well 
established (Zetterstrom et al., 1982; Hagberg et al, 1987; During and Spencer 
1992). Direct measurements of NO using microdialysis are currently 
impossible given its extremely short half-life, in the order of seconds (Snyder 
and Bredt 1992) and its extremely low basal concentrations, reported to be 
10"8 M (Malinski et al. 1993). For these reasons we chose to measure the 
release of citrulline, an amino acid which is produced in a 1:1 molar ratio 
with nitric oxide (Leone et al. 1991; Bush et al. 1992). Amino acids are 
commonly measured in microdialysis samples, and a change in citrulline 
production has been used as index of NO synthesis in the past (Rogers and 
Ignarro 1992; Snyder and Bredt 1992). 
In addition to the more common use of microdialysis, to measure the 
concentration of substances in the interstitium, it also enables the local 
delivery of pharmacological agents to the extracellular environment. This is 
particularly important for this investigation because intravenous application 
of substances could produce systemic effects or influence vascular endothelial 
cells to change blood flow in the hippocampus. Such a response could not be 
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attributed solely to neuronal activity. For this study the glutamate agonist 
NMDA, was infused to produce a local increase in neuronal activity. Since 
NMDA has been shown to have no direct effect on vascular smooth muscle 
(Faraci and Breese 1993) and as astrocytes do not express functional NMDA 
receptors (Bowman and Kimelberg 1984), the changes observed in blood flow 
can be assumed to be produced from the local activation of neurons. In 
addition the results displayed in Table I demonstrate that no significant 
changes in the systemic parameters occurred with the application of NMDA 
through the microdialysis probe. 
The major problems with the combined technique are the intracerebral 
surgical placement of the laser doppler probe in relation to the microdialysis 
probe, the trauma induced by probe insertion, and the need for an 
anesthetized animal to avoid movement artifact. Because of the limited 
volume of tissue measured by the laser doppler, the tip of the probe has to be 
within 1.0 mm of the dialysis membrane. This insures that the doppler 
monitors the neuronal environment manipulated by substances infused 
through the microdialysis probe (see Figure la & lb). The larger the volume 
of activated tissue measured by the laser doppler, the more likely a response 
will be observed. This variability in surgical placement undoubtedly 
produces a considerable variation between animals, and cannot be avoided 
without direct observation of the tissue at the time of implantation. 
The majority of cerebral laser doppler studies have been limited to 
measurements of surface cortical flow. The stereotaxic implantation of the 
laser doppler enables the measurements of deep structures, however this may 
lead to significant tissue trauma. In this study such trauma is limited 
through the use of metal stylets which are inserted during the initial surgery. 
The stylets, placed through both microdialysis and laser doppler guide 
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cannulae, limit the acute injury in the tissue occupied by the probes at the 
time of their subsequent insertion through the guide cannulae. This pre¬ 
placement of stylets has recently been shown to enable measurements of both 
calcium and TTX dependency of neurotransmitter release within two to three 
hours of microdialysis probe placement (Devine et al 1993). 
In order to obtain accurate results with the laser doppler, the tissue 
examined must remain motionless in relation to the laser doppler probe, 
requiring an anesthetized animal. Unfortunately many anesthetics have a 
significant effect on the cardiovascular system, cerebral blood flow, and 
neuronal activity. For this study we chose to use a combination of a- 
chloralose and urethane. This anesthetic regimen has major advantages over 
other anesthetics. a-Chloralose/urethane has been shown to produce stable 
laser doppler recordings of cerebral blood flow and not inhibit blood flow 
response to stimulation (Lindauer et al 1993), it preserves the coupling of 
cerebral function to cerebral metabolism (Ueki et al 1992), and it has limited 
effects on the cardiovascular system (Alvarez-Buylla 1951; Bijagkuman 1956). 
Due to these characteristics the combination of a-chloralose/urethane is 
particularly suited for this type of study. 
In spite of the limitations - the degree of accuracy needed with surgical 
placement, the tissue trauma produced, and the need for an anesthetized 
animal - it is evident from the results obtained in this study that this 
combination of techniques has definitely proven to be a powerful tool in the 
investigation the coupling between rCBF and neuronal activity. 
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B.) NO and Adenosine: 
Mediators Coupling rCBF to Neuronal Activity 
Based on previous studies investigating the relationship between rCBF 
and neuronal activity, we expected to observe an increase in blood flow with 
the activation of hippocampal neurons. Neuronal activation was produced 
through the infusion of NMDA through the microdialysis probe. NMDA is a 
specific glutamate receptor agonist which acts at the receptor named after 
itself, the NMDA receptor. These receptors have been identified throughout 
the hippocampus with the highest densities in the CA1 and dentate hilus, 
targets of the Schooner collateral and perforant pathway respectively (Cotman 
and Iversen 1987; Cotman et al 1988). With exogenous application of NMDA 
or endogenous release of excitatory neurotransmitters, such as glutamate and 
aspartate, the receptor complex is stimulated and activates a voltage sensitive 
ion channel. As with other glutamate receptor channels an efflux of Na+ and 
an influx of K+ occurs with activation, but in addition the NMDA gated 
channel allows an influx of Ca+2 ions (Ascher and Nowak 1987). 
Since the activation of neuronal NOS is dependent on Ca+2, the ability 
of the NMDA receptor to increase intracellular Ca+2 has linked it to the 
activation of NOS and NO production (Snyder and Bredt 1992). This has 
previously been shown to occur in suspensions of cerebellar cells in vitro 
(Garthwaite et al 1988). In order for NO to participate in the regulation of 
rCBF in the hippocampus there must be neurons within this region shown to 
contain NOS. Using immunohistochemical treatments this enzyme has been 
localized throughout the brain, including the hippocampus, particularly the 
dentate hilus (Bredt et al 1990). Another technique to localize NOS 
containing neurons is to stain for NADPH diaphorase. In the oxidation of L- 
arginine to NO, a co-factor is required to donate electrons. This function is 
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carried out by NADPH. It has been shown that staining for NADPH 
diaphorase is actually a means of staining for NOS since this enzyme is the 
sole source of NADPH activity in neurons (Snyder and Bredt 1992). Using 
this technique it has more recently been shown that NOS containing neurons 
within the hippocampus have processes intimately related with microvessels 
(Schottler et al 1993). Therefore the elements necessary to produce NO are 
present in the hippocampus. 
Adenosine release has also been shown to occur within the 
hippocampus. During electrical stimulation of rat transverse hippocampal 
slices an increase in the release of adenosine occurs. This release is in part 
Ca+2 dependent and has been thought to occur by both classic 
neurotransmitter mechanisms and via breakdown of cellular AMP during 
increased metabolism (Jonzon and Fredholm 1985). NMDA has been shown 
to be a powerful stimulator of adenosine release. At a concentration of 30 |iM 
NMDA a maximal response of adenosine release was produced in rat brain 
slices (White et al 1993). In order to produce a vasodilating effect adenosine 
must interact with a specific class of purinergic receptor, the P2 receptor (Ngai 
and Winn 1993). The existence of such receptors within the hippocampus has 
been demonstrated through increases in cAMP production with adenosine 
application in vitro (Fredholm et al 1982). As with NO all the necessary 
elements for adenosine to mediate the coupling of rCBF to neuronal activity 
are present in the hippocampus. In addition adenosine has also been 
hypothesized to have other important neuromodulatory effects in the 
hippocampus, such as acting as the mediator of seizure arrest (During and 
Spencer 1992). 
If a direct relationship exists between neuronal activity and rCBF, one 
would expect larger increases in activation to produce greater increases in 
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rCBF. We observed such an effect by increasing the concentrations of NMDA. 
From the results it is clear that a dose dependent response of rCBF to 
neuronal stimulation occurs in the hippocampus. However this could also 
be explained by a potentiation of mediator release due to subsequent 
stimulations, instead of increasing activity levels. Such a mechanism has 
been described to explain long term potentiation within the hippocampus. 
Our data do not support this notion since repeated stimulation with the same 
concentration of NMDA did not produce any facilitation in the response of 
rCBF. It can therefore be assumed that the response of rCBF is activity 
dependent, and by increasing the concentration of NMDA an increase in 
activity is achieved by either increasing the number of activated neurons 
and/or increasing their firing frequency, leading to a heightened response in 
rCBF. 
Both adenosine and citrulline, an indirect index of NO production, 
increased as expected with NMDA stimulation. Each displayed an increase in 
their extracellular concentrations, although a dose dependence did not prove 
to be significant. The increase in citrulline does not definitively indicate an 
increase in NO. Other sources of citrulline exist, such as the urea cycle. 
Therefore the effect of NOS inhibitors must be assessed in order to determine 
if the citrulline measured by microdialysis is at least in part produced through 
the formation of NO. Although a dose dependent response in citrulline 
release did not prove to be significant, a general trend toward increasing 
release with increasing concentrations of NMDA is apparent. The increase of 
adenosine is more complex than that of citrulline since there was a 
considerable, but not statistically significant, decrease in the concentration at 
200 pM NMDA. This could possibly be explained by a recent study which 
demonstrated an inhibitory effect of NMDA neurotransmission through 
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extracellular adenosine release. This inhibition is thought to occur at a 
presynaptic PI purinergic receptor, and can be overcome by excessive 
amounts of NMDA, at concentrations of 500 pM NMDA. This excess of 
glutamate agonist is hypothesized to activate a spare group of NMDA 
receptors (White et al 1993). Perhaps this is a mechanism by which adenosine 
is able to modulate its own release as well as the release of other 
neurotransmitter. 
Although the concomitant increase in the proposed mediators and 
rCBF lends support to the hypothesis that they mediate the increase in rCBF it 
does not establish a cause and effect relationship. To strengthen this 
hypothesis one can demonstrate increases in rCBF with direct application of 
the possible mediator, or show that the response of rCBF during activation is 
decreased by inhibiting the production or action for these mediators. Direct 
application of NO through the infusion of SNAP produced a significant 
increase in rCBF. These results are not surprising and only support the 
vasodilator action of NO. 
NAME acts as a competitive inhibitor of NOS, and therefore will 
decrease the production of NO. If NO is a mediator which couples rCBF to 
neuronal activity then by inhibiting its production the response of rCBF 
during activation should be decreased. The response of rCBF to NMDA was 
significantly decreased but not abolished with the infusion of NAME, 
indicating that the response of rCBF during neuronal activation is only in 
part mediated by NO. In addition there was a significant decrease in the 
amount of citrulline produced with NMDA stimulation during NAME 
infusion. This supports the hypothesis that citrulline can act as an index of 
NO production, and that the increase of citrulline occurring with NMDA is 
accompanied by an increase in NO. The amount of NAME used may be 
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sufficient to produce a total block of NO production since there was no 
difference between the concentrations of citrulline when NAME was given 
alone and with NMDA. Since NAME is a competitive inhibitor its effects 
should be attenuated with the application of the endogenous substrate, 
L-arginine. When combined with L-arginine, the decrease produced by 
NAME in rCBF was not as great as when NAME was given alone. In addition 
it appears that additional administration of endogenous substrate increases 
rCBF. Both of these responses are presumably due to an increase in the 
production of NO. These claims however could not be substantiated since the 
inclusion of such a high concentration of L-arginine in microdialysis samples 
precluded analysis. The excessive amounts of L-arginine utilized all the 
derivatizing agent, necessary to identify amino acids with HPLC analysis. 
Even so, these results support the hypothesis that NO plays a part in coupling 
rCBF to neuronal activation. 
The effects of inhibiting adenosine vasodilatation also show that the 
response of rCBF to NMDA stimulation is in part mediated through the 
release of adenosine. The antagonism of the response is produced by blocking 
the receptor for adenosine instead of blocking its production. The agent used 
was a derivative of the methyl-xanthine drug group, which includes caffeine, 
8-THEO. This agent is not specific for either the Pi or P2 purinergic receptor, 
however its ability to antagonize adenosine vasodilatation is mediated 
through blockade of the P2 receptor (Ngai and Winn 1993). As with NAME, 
the response to NMDA stimulation was also attenuated with 8-THEO, 
indicating that adenosine is necessary to couple rCBF to neuronal activation. 
Although blocking the action of both mediators attenuated the 
response of rCBF to NMDA activation, 8-THEO produced a greater percentage 
decrease in the response than NAME. A possible explanation for the 
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seemingly more powerful effect of adenosine in rCBF may be due to the fact 
that adenosine is released as both a neurotransmitter and metabolite. 
Therefore two sources allow a greater accumulation of the mediator and a 
greater response produced. A more likely explanation comes from recent data 
which demonstrated a 50% reduction of the response of rCBF to adenosine 
with the administration of a NOS inhibitor (Niwa 1993). A hypothesis which 
may explain these results is that adenosine may activate flow through two 
mechanisms. A direct mechanism by binding to the P2 receptors and 
increasing intracellular cAMP, and an indirect mechanism by activating the 
production of NO. Adenosine may activate NO production by binding to 
presynaptic receptors which have previously been hypothesized to modulate 
neurotransmission in the hippocampus (Dunwiddie 1980). Adenosine may 
therefore play a very complex role in the regulation of rCBF. Not only 
because of two sources of production, but also by increasing rCBF through 
direct vasodilatation, and by increasing NO production. 
There may also be a role for both NO and adenosine in maintaining 
basal blood flow within the hippocampus. Both mediators are capable of 
being synthesized and released outside of the classic neurotransmitter 
mechanisms, and are therefore action potential independent. Adenosine can 
be released through the metabolic pathways, and the constitutive isoform of 
NOS is continually producing NO which simply diffuses out of the cell. It is 
possible that these two mediators are released during basal neuronal activity 
and maintained at a certain extracellular concentration, enough to exert a 
tonic effect. This is evident from the data obtained when both NAME and 8- 
THEO were applied alone. In both cases a significant decrease in baseline 
rCBF occurred. In addition the decrease in citrulline produced when NAME 
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is given alone indicates that a certain amount of NO is produced by the 
neuron even when it is not stimulated. 
Although the application of NMDA produces neuronal activation this 
is not a physiological form of stimulation within the hippocampus. In order 
to determine if this response is indeed occurring during normal physiological 
activity an endogenous stimulation must be applied. This was carried out 
through the electrical activation of the perforant pathway. This pathway 
delivers a major sensory input to the hippocampus from the entorhinal 
cortex. This cortical structure in turn receives input from association cortices, 
the olfactory cortex, thalamic nuclei, and the amygdala. The perforant 
pathway enters the hippocampal fissure and terminates throughout the 
hippocampus, however the dentate gyrus contains a high density of fibers. 
Here the terminals of the perforant pathway make excitatory synapses on the 
spines of granule cells (Brown and Zador 1990). Stimulation of the perforant 
path should produce an increase in the local activity of the dentate gyrus and 
produce an increase in rCBF to this area. This assumption is confirmed by the 
results obtained from this study. Not only was a definite increase in rCBF of 
the CA1/dentate hilus produced with stimulation of the perforant pathway, 
but this response appears to be dose dependent. This is evident from the 
statistically significant differences between the increases occurring with the 2 
volt and 5 volt stimuli. Unfortunately at the present time the level of 
citrulline and adenosine have not been determined for these microdialysis 
samples due to a technical error in equipment and lack of time. This data 
however will be available shortly. 
Based on these results it seems clear that both NO and adenosine act to 
couple rCBF to increasing neuronal activity within the CA1/dentate hilus of 
the hippocampus. These mediators are not likely to be unique to the 
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hippocampus, and probably mediate this response throughout the central 
nervous system. Both are potent vasodilators, are present throughout the 
brain, released with increasing neuronal activity, and are themselves tightly 
regulated, all the characteristics necessary for a ubiquitous coupling agent. 
Since the increases in the two putative mediators did not parallel the change 
in blood flow, and inhibiting these mediators could not totally abolish the 
response of activated flow, additional factors are likely to be involved. Given 
the host of other candidates this is very possible (Iadecola 1993). In addition 
since adenosine has been shown to have a negative effect on NMDA receptor 
neurotransmission (White et al. 1993), and that NO has a negative feedback 
on NOS (Rogers and Ignarro 1992), a simple linear relationship between the 
release of these mediators and effects on rCBF is unlikely. At this juncture a 
plausible scenario within the hippocampus, and other areas of the brain, is 
that NO and adenosine act to initiate the response in rCBF, but the classical 





From the results obtained the following conclusions can be drawn: 
1. The combination of LDF and intracerebral microdialysis is a 
valuable tool to investigate the coupling of neuronal activity to rCBF. LDF 
allows continuous monitoring of rCBF and microdialysis characterizes the 
extracellular fluid for the release of possible mediators. Also microdialysis 
can deliver various pharmacological agents to manipulate the local neuronal 
environment without involving additional tissues. 
2. Neuronal activation is coupled to rCBF in a dose dependent 
manner, under both pharmacological stimulation using NMDA, and synaptic 
stimulation by electrical stimulation of the perforant pathway. This 
heightened response may be due to an increase in the number of neurons 
releasing transmitter and/or an increase in the amount of transmitter 
released by each neuron. 
3. Both NO and adenosine are involved in the coupling of rCBF to 
neuronal activity, and are also involved with maintaining basal flow. During 
stimulation with NMDA both agents demonstrate an increased concentration 
in the extracellular fluid. The response of NMDA induced rCBF was 
antagonized by the application of an inhibitor to NO synthesis and a receptor 
blocker to adenosine. The antagonism of the NOS inhibitor is reduced when 
an excessive amount of the endogenous substrate for NO synthesis is 
available. When these substances are given under baseline activity there is 
also a significant reduction of basal rCBF. 
Figure 10 is a schematic presentation of how NO and adenosine may 
mediate an increase in rCBF. 
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4. It is likely that additional factors are involved in this relationship 
since inhibiting either NO or adenosine could not abolish the response 
produced with NMDA stimulation. 
5. Measuring the extracellular concentrations of citrulline is an 
indirect measure of NO production. The extracellular concentration of 
citrulline increased during NMDA stimulation and decreased with 
application of NAME, the inhibitor to NO synthesis. This is the pattern 




Physiological Parameters at the onset of 
experiment, prior to 500 |iM NMDA, and 
during 500 pM NMDA stimulation. 
Basal Pre SOOfiM 500jiM 
Blood Pressure (mm 
Hg) 
119.5 ±13.0 93.7 ±9.9 95.0 ± 10.6 
PO2 (mm Hg) 78.1 ±4.1 64.9 ± 5.5 67.1 ±4.5 
PCO2 (mm Hg) 38.1 ± 1.4 37.0 ± 3.8 35.8 ±3.4 
PH 7.39 ± 0.01 7.38 ± 0.04 7.39 ± 0.03 
Hematocrit 39.0 ± 0.6 35.3 ± 2.7 37.0 ±2.1 
Table I. Data is represented as the mean + SEM. Blood pressure measurements are based 
on n=4, and blood gas parameters are based on n=3. No statistically significant differences 




Figure la. Schematic representation of a posterior view outlining the microdialysis 
and laser doppler probe placement into the CA1/dentate hilus of the rat hippocampus. Each 
division of grid equals 200 pm. Both microdialysis and laser doppler probes are drawn to scale. 
Figure lb. Photograph 
demonstrating the anterior view of a 
rat brain slice. Defect produced by the 
microdialysis probe is on the right and 
by laser doppler probe on the left. Each 
division represents 1.0 mm. 
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Response of Hippocampal Blood Flow to 
NMDA Stimulation 
Figure 2. Local hippocampal blood flow responds to increasing concentrations of 
NMDA in a dose dependent manner. Data are represented as % of baseline flow ± SEM. The 
increase at 50 pM is 106.8±2.3%, at 100 pM is 120.016.3%, at 200 pM is 148.0116.6%, and at 
500 pM NMDA is 191.4 ±20.4%. Each increase proved to be a statistically significant from the 
baseline and from preceding responses (p<0.05). 
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Laser Doppler Recordings 
500|iM NMDA 
Figure 3. Laser doppler recordings demonstrating the dose dependent response of 
rCBF to increasing concentrations of NMDA. The top trace of each pair represents blood flow 
and the lower trace is the concentration of moving blood cells. The arrows indicate the 
approximate arrival time of NMDA to the tissues and the values used for baseline blood flow. 
Each vertical division of chart paper represents 20 seconds. 

Response of Extracellular Citrulline to 
NMDA Stimulation 
0 50 100 200 500 
Concentration of NMDA (|iM) 
Figure 4a. Extracellular citrulline increases with NMDA stimulation. Data are 
represented as % of baseline levels ± SEM. The increase at 50 pM is 128.9±7.4%, at 100 pM is 
141.2+15.4%, at 200 |iM is 147.2±20.4%, and at 500 pM NMDA is 196.8±22.3%. All responses 
proved to be statistically significant from baseline values, but a dose dependent response did 
not prove to be statistically significant (p<0.05). 
Response of Extracellular Adenosine to 
NMDA Stimulation 
Figure 4b. Extracellular adenosine increases with NMDA stimulation. Data are 
represented as the % of baseline adenosine ± SEM. The increase at 50 pM is 355.6±112.7%, at 
100 pM is 1233.5+509.2%, at 200 pM is 833.9+378.5%, and at 500 pM NMDA is 1270.2+958.3%. 
All responses proved to be statistically significant from baseline values, but a dose dependent 
response did not prove to be statistically significant (p<0.05). 
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Concentration of SNAP (mM) 
Figure 5. Infusion of the NO donor, SNAP, produces an increase of 137.0+5.8% of 
baseline. The increase in rCBF was statistically significant from baseline (p<0.05). 
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Effect of NAME and 8-THEO on Baseline and 
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^ 5 mM NAME 
500 (iM 8-THEO 
Baseline 
NMDA only 
0 0 200 200 
Concentration of NMDA (^M) 
Figure 6. Both NAME and 8-THEO decrease basal rCBF and attenuate the response 
to NMDA stimulation. 5mM NAME reduces rCBF to 77.0±3.0%(n=9) of baseline and 500 pM 8- 
THEO to 74.9+2.0% (n=7) of baseline. The response to 200 pM NMDA is reduced from 
164.0+17.4% to 125.G±6.5% of baseline with 5mM NAME (n=7) and from 138.0±8.0% to 
108.0+3.4% of baseline with 500 pM 8-THEO (n=5). Each reduction from baseline as well as 
from NMDA stimulated flow proved to be statistically significant (p<0.05). 
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Effect of NAME on Baseline and NMDA 


























0 0 200 200 
Concentration of NMDA (|uM) 
Figure 7. NAME decreases the level of extracellular citrulline from baseline and 
reduces the response to NMDA stimulation. Infusion of 5mM NAME decreases basal 
extracellular citrulline to 64.1±5.9% of baseline. The response of extracellular citrulline to 200 
(iM NMDA is attenuated from 134.1±4.4% to 67.6±9.2% of baseline. The decreases produced by 
5mM NAME from basal and NMDA stimulated levels of extracellular citrulline were both 
statistically significant (p<0.05). There was no statistically significant difference between the 
decreases in extracellular citrulline produced by 5 mM NAME under basal and NMDA 
stimulated conditions. 

Effect of L-arginine to Baseline and NAME 
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Concentration of NAME (mM) 
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NAME only 
Figure 8. L-arginine increases basal rCBF and inhibits the decrease produced by 
NAME. 100 mM L-arginine alone increases rCBF to 113.0+2.9% of baseline, and attenuates the 
response to 5 mM NAME from 77.0+3.0% to 92.6+2.2% of baseline. The increase produced from 




Response of Hippocampal Blood Flow to 
Perforant Pathway Stimulation (n=2) 
-10 0 10 20 30 40 50 60 
Time (sec) 
Figure 9. The data obtained thus far demonstrate that hippocampal blood flow 
responds to perforant pathway stimulation in a dose dependent manner. The response to 
5 volts reached a peak at 179.0+5.4% of baseline, while the response to 2 volts only peaked at 
122.0+6.0% of baseline. Even with two subjects, a statistically significant difference between 
the two responses was demonstrated (p<0.05). In addition the response from 5 volts lasted 25 
seconds after the stimulus while with 2 volts baseline flow was obtained only 10 seconds after 
stimulus. Each response occurred at the onset of stimulation without an appreciable time lag. 

73 
Schematic representation of the mechanisms by which NO and adenosine may increase rCBF. The 
upper portion of the diagram is the NO pathway. The bottom half demonstrates the three ways in 
which adenosine is released to increase rCBF; (1) through the extracellular breakdown of neuronally 
released AIT, (2) through the direct release as a neurotransmitter, and (3) from the breakdown of AMP 
through the metabolic pathways of the cell. Not demonstrated in this diagram is the possible effect in 
which adenosine may stimulate NO release. 
/ 
APPENDIX 
A.) Laser Doppler Flowmetry 
i. History 
Only four years after the experimental development of the laser 
(Maiman I960), flow profiles in transparent tubes were demonstrated by 
utilizing laser light (Yeh and Cummins 1964). This lead to its use in 
measuring air flow in wind tunnels, and was known as laser doppler 
anemometry (Durst et al 1976). 
In 1972 the first measurements of blood flow using laser doppler 
techniques were done in the rabbit retina (Riva et al 1972). The technology at 
this time required the use of a 10 mW laser to overcome the low signal to 
noise ratio. Not until improvements in the system occurred, allowing a 
reduction in the power of the laser to 18 pW, were blood flow profiles in the 
human retina possible (Tanaka and Riva 1974). Laser doppler has also been 
coupled to microscopes (Einav et al 1975) and optical fibers inserted directly 
into blood vessels (Kajiya et al 1981) in order to obtain blood flow profiles. In 
1975, Stern used a 15 mW He-Ne laser to measure blood flow through the 
skin micro-circulation during alcohol intake and increased venous pressure. 
Laser doppler was introduced for clinical use by Holloway and Watkins in 
1977, however one year later these same authors demonstrated that 
measurements could only be made only 50% of the time due to mode 
competition in the laser cavity (Watkins and Holloway 1978). These 
difficulties were overcome with the development of a dual channel detector 
system, which increased the signal to noise ratio, and a signal processor which 
' 
gave a linear response to flow under low to moderate red cell velocities and 
volumes (Tenland 1982). 
ii. Interaction of Laser Light within Tissues 
Laser light which illuminates a tissue will be scattered in a diffuse 
pattern due to the variations in the tissue refractive index. The depth of 
penetration is dependent on a number of variables, including the wavelength 
of laser light used (in this study the wavelength was 632.8 |im - red light), the 
pigmentation of the tissue, and the hemoglobin content of the tissue. Light is 
predominantly scattered by static tissues, however a component of the 
incident light will be scattered by mobile tissues, i.e. blood cells. This light 
will undergo a frequency shift according to the Doppler effects. Light which is 
reflected directly back to its source will undergo the maximum frequency 
shift. In tissues with a high density of moving blood cells the light will 
undergo a multitude of frequency shifts. Most of the light incident on the red 
blood cells is reflected forward, away from its origin, secondary to the 
irregular shape of the cells, their high refractive index, and since their size is 
greater than the wavelength of laser light, according to the Rayleigh-Debye 
theory. Therefore the magnitude of frequency shifted light returning to the 
source is smaller than light which is scattered from static tissue. 
iii. Detection of the Reflected Laser Light 
Light which returns to the doppler unit is presented to the 
photodetectors. If the light were scattered by a stationary object, the beam 
would produce a speckle pattern from the positive and negative interferences 
of the light. If a portion of this light is reflected from a moving object the 
intensity of the speckle pattern will be less pronounced. This is due to rapid 

fluctuations in the interference pattern caused by the shifting in frequencies 
according to the Doppler effect. The naked eye would be unable to detect 
these changes in speckle pattern, however a rapid photodetector could. These 
fluctuations are based on the magnitude and frequency of the number of 
objects in motion and their velocities. The photodetector monitors the 
individual changes of each granule making up the speckle pattern and by 
adding them together produces an output signal. The magnitude of this 
signal is proportional to the square root of the number of fluctuating speckle 
points detected. 
iv. Derivation of Photodetector Output Signal 
Returning laser light is composed of both shifted and unshifted light, 
which produces three forms of output. A DC-term which is proportional to 
the intensity of returning light, a homodyne term which is composed of the 
Doppler shifted light, and a heterodyne term which is composed of both 
Doppler shifted and unshifted light. In tissues with low to moderate red cell 
densities the homodyne term will drop out since the average of shifted light 
is insignificant compared to the average of unshifted light. An output signal 
is then generated based on the following equation: 
Vout={k0J00coP(o)) dco} 
Vout = output signal; ko = constant; P(co) = power spectral density 
In tissues with a high density of red blood cells, e.g. a dilated fingertip, this 
relationship is not valid since the homodyne term is no longer insignificant 
and an incident beam of light undergoes multiply scattering. 
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Ideally the laser doppler should utilize a monochromatic source of 
light, however small amounts of variation in both frequency and amplitude 
of the light illuminating the tissue will occur. These variations will produce 
mode interference on the photodetector which will induce error in the laser 
doppler recording. This limitation is overcome with the use of a pair of 
photodetectors, and forming the difference between the two output signals. 
v. Converting the Photodetector Signal into Useful Information 
The signal produced by the photodetector must be processed in order to 
gain useful information. This is done by the conversion into a continuous 
real-time electrical signal which can be transmitted to a computer or chart 
recorder and is a reflection of the blood flow. In order for this to be accurate 
two assumptions are necessary: 
1. The portion of laser light undergoing a frequency shift is 
approximately linearly related to the volume of moving blood cells. 
2. The average frequency shift is proportional to the average red 
blood cell velocity. 
These assumptions have been proven to be correct in tissues of low to 
moderate red blood cell density. A signal processor is therefore able to obtain 
an output which is linearly related to the flow of red blood cells, which is 
equal to the number of moving red blood cells multiplied by their velocity. 
In highly perfused tissues these assumptions are less than ideal secondary to 
an increased complexity between the frequency shifts and flow of red blood 
cells and a decreased penetration of the laser light. 
vi. The Laser Doppler Unit 
The main unit contains a He-Ne laser which emits a beam with a 
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wavelength of 632.8 pm, in the spectrum of red light. This laser light is sent 
to the tissue through a fiber optic guide. The light guide for this study 
contained three parallel optical fibers arranged in a triangular configuration. 
One acts as the emitting fiber from which the laser light enters the tissue. The 
remaining two optical fibers act as receivers and return the scattered light to 
the doppler unit. Variations in the distance between the two receiving fibers 
will increase the depth of measurements since light reflected by a greater 
angle can be received. 
The returning light enters the doppler unit and is processed by the pair 
of photodetectors. The output signal of each detector is sent to the signal 
processor which transforms the outputs into an electrical signal which drives 
a pen on a chart recorder. A hard copy of the laser doppler results is obtained 
and the percent increase from baseline can be determined. 
B.) Microdialysis 
i. History 
In order to obtain an understanding of the factors which mediate 
cellular responses the extracellular fluid compartment has to be analyzed. 
Determining the concentrations of substances in the plasma cannot be used as 
a reflection of the interstitial concentration since the substance may have 
completely different kinetics between the two compartments. Various 
methods have been applied to obtain the interstitial concentrations of various 
substances, however the one technique which has become the standard, 
especially in measuring brain interstitial fluid, is microdialysis. 
In the mid 1960's the idea of a separate compartment surrounded by a 
dialysis membrane was introduced. These initial studies utilized a "dialysis 
sac," containing a solution of 6% dextran in normal saline, which equilibrated 

with the extracellular environment. This sac was implanted into the tissues 
and after a certain time period removed so that the substances within the sac 
could be measured (Bito et al 1966). This idea progressed into the "dialytrode" 
which consisted of a push-pull cannula with a dialysis membrane connecting 
the inlet and outlet (Delgado et al 1972). A simple version of the 
microdialysis probe was produced in 1974 and used to measure the release of 
dopamine during amphetamine stimulation (Ungerstedt and Pycock 1974). 
Further development has lead to the modern microdialysis probe which can 
be implanted into the brain and other tissues much like an electrode. The 
technique has become so sophisticated that it has gained clinical use (During 
and Spencer 1992). 
ii. Characteristics of Microdialysis 
The following list of features of microdialysis have lead its popularity 
in measuring the interstitial fluid of various organs, particularly the brain 
(Ungerstedt 1991): 
1. Microdialysis only samples the extracellular fluid 
2. Continuous sampling is possible, even over days 
3. It can not only recover endogenous substances, but it can also 
locally deliver pharmacological agents to manipulate the 
tissues. 
4. It actually removes a representative of the substance released 
in the extracellular fluid, distinguishing it from 
implantable bioelectrodes. 
5. It produces minimal tissue injury 
6. The membrane does not allow enzymes, and other large 
molecules to cross, so that samples are not degraded. 
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7. Various lengths of tissue can be monitored depending on the 
length of the dialysis membrane. 
8. Probes can be calibrated in vitro to determine the efficiency of 
removing a substance from the extracellular 
environment. 
iii. Theory of Microdialysis 
The basic principle behind microdialysis is that substances will diffuse 
across the dialysis membrane according to their concentration gradient. The 
microdialysis probe therefore imitates the passive function of tissue capillary. 
Substances with a higher concentration in the extracellular compartment will 
diffuse into the dialysate, while the reverse occurs with substances of higher 
concentrations in the dialysate. 
The complexity of the microdialysis technique occurs from the 
interactions between the tissue, the probe, and the dialysate. With initial 
insertion of the probe the tissue trauma produced and the initial influx of 
substances into the probe make steady state measurements impossible. In 
addition this trauma also produces a decrease in rCBF and an increase in 
glucose metabolism. Therefore an initial time period must pass before a 
stable tissue baseline can be established. This time period depends on the 
relative size of the probe compared to the tissue studied, and in the brain is 
roughly 10-20 minutes (Ungerstedt 1991). Another issue is the time over 
which accurate measurements can be obtained and depends on the tissue's 
reaction to the probe, the substances being measured, and the type of 
instrument used. 
The recovery of substances from the extracellular fluid is dependent on 
the following factors (Benveniste 1989): 

1. The length of diffusable membrane 
2. Flow of the dialysate through the probe 
3. Ability of the substance to diffuse through the extracellular 
space. 
4. Properties of the dialysis membrane. 
Results of microdialysis are distinguished between absolute recovery 
and relative recovery. Absolute recovery is the total amount of substance 
recovered from the probe and will fluctuate with release of a substance by the 
tissue. Relative recovery is the concentration of a substance leaving the probe 
expressed as a percentage of the concentration outside the dialysis membrane 
(Ungerstedt 1991). In this study the absolute recovery of microdialysis 
samples was measured and the changes in concentrations expressed as the 
percent of the baseline's concentration. 
iv. The Microdialysis Probe 
Today the method of microdialysis is so popular that manufactured 
probes can be obtained, however in this study the probes were constructed. A 
detailed description of the probe's construction is available in the "Materials 
and Methods" section. The microdialysis probe is a simple instrument 
consisting of an inlet, an outlet, and the membrane sac. The inlet delivers the 
dialysate to the membrane sac. Here the dialysate equilibrates with 
extracellular fluid. The fluid is continuously pumped out of the probe 
through the outlet. It is then collected and analyzed. 
■ 
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v. Diagram of Microdialysis Probe 
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